```

[109th Congress Public Law 469]
[From the U.S. Government Printing Office]

[DOCID: f:publ469.109]

[[Page 3501]]

   OFFICE OF NATIONAL DRUG CONTROL POLICY REAUTHORIZATION ACT OF 2006

[[Page 120 STAT. 3502]]

Public Law 109-469
109th Congress

                                 An Act

 
       To reauthorize the Office of National Drug Control Policy 
              Act. <<NOTE: Dec. 29, 2006 -  [H.R. 6344]>> 

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress <<NOTE: Office of National Drug 
Control Policy Reauthorization Act of 2006.>> assembled,
SECTION 1. SHORT TITLE, REFERENCE, AND TABLE OF CONTENTS.

    (a) Short <<NOTE: 21 USC 1701 note.>> Title.--This Act may be cited 
as the ``Office of National Drug Control Policy Reauthorization Act of 
2006''.

    (b) Amendment of Office of National Drug Control Policy 
Reauthorization Act of 1998.--Except as otherwise expressly provided, 
whenever in this Act an amendment or repeal is expressed in terms of an 
amendment to, or repeal of, a section or other provision, the reference 
shall be considered to be made to a section or other provision of the 
Office of National Drug Control Policy Reauthorization Act of 1998 
(Public Law 105-277; 21 U.S.C. 1701 et seq.).
    (c) Table of Contents.--The table of contents for this Act is as 
follows:

Sec. 1. Short title, reference, and table of contents.

  TITLE I--ORGANIZATION OF OFFICE OF NATIONAL DRUG CONTROL POLICY AND 
                       ROLES AND RESPONSIBILITIES

Sec. 101. Amendments to definitions.
Sec. 102. Establishment of the Office of National Drug Control Policy.
Sec. 103. Appointment and responsibilities of the Director.
Sec. 104. Amendments to ensure coordination with other agencies.
Sec. 105. Budgetary matters.

              TITLE II--THE NATIONAL DRUG CONTROL STRATEGY

Sec. 201. Annual preparation and submission of National Drug Control 
           Strategy.
Sec. 202. Performance measurements.
Sec. 203. Annual report requirement.

            TITLE III--HIGH INTENSITY DRUG TRAFFICKING AREAS

Sec. 301. High Intensity Drug Trafficking Areas Program.
Sec. 302. Funding for certain high intensity drug trafficking areas.
Sec. 303. Assessment.

                          TITLE IV--TECHNOLOGY

Sec. 401. Counterdrug Technology Assessment Center.

                 TITLE V--NATIONAL YOUTH MEDIA CAMPAIGN

Sec. 501. National Youth Anti-Drug Media Campaign.

       TITLE VI--AUTHORIZATIONS AND EXTENSION OF TERMINATION DATE

Sec. 601. Authorization of appropriations.
Sec. 602. Extension of termination date.

                      TITLE VII--ANTI-DOPING AGENCY

Sec. 701. Designation of United States Anti-Doping Agency.

[[Page 120 STAT. 3503]]

Sec. 702. Records, audit, and report.
Sec. 703. Authorization of appropriations.

                    TITLE VIII--DRUG-FREE COMMUNITIES

Sec. 801. Reauthorization.
Sec. 802. Suspension of grants.
Sec. 803. Grant award increase.
Sec. 804. Prohibition on additional eligibility criteria.
Sec. 805. National Community Anti-Drug Coalition Institute.

              TITLE IX--NATIONAL GUARD COUNTERDRUG SCHOOLS

Sec. 901. National Guard counterdrug schools.

 TITLE X--NATIONAL METHAMPHETAMINE INFORMATION CLEARINGHOUSE ACT OF 2006

Sec. 1001. Short title.
Sec. 1002. Definitions.
Sec. 1003. Establishment of clearinghouse and advisory council.
Sec. 1004. NMIC requirements and review.
Sec. 1005. Authorization of appropriations.

                   TITLE XI--MISCELLANEOUS PROVISIONS

Sec. 1101. Repeals.
Sec. 1102. Controlled Substances Act amendments.
Sec. 1103. Report on law enforcement intelligence sharing.
Sec. 1104. Requirement for South American heroin strategy.
Sec. 1105. Model acts.
Sec. 1106. Study on iatrogenic addiction associated with prescription 
           opioid analgesic drugs.
Sec. 1107. Requirement for strategy to stop Internet advertising of 
           prescription medicines without a prescription.
Sec. 1108. Requirement for study on diversion and inappropriate uses of 
           prescription drugs.
Sec. 1109. Requirement for Afghan Heroin Strategy.
Sec. 1110. Requirement for Southwest Border Counternarcotics Strategy.
Sec. 1111. Requirement for Scientific Study of Mycoherbicide in Illicit 
           Drug Crop Eradication.
Sec. 1112. Requirement for Study of State Precursor Chemical Control 
           Laws.
Sec. 1113. Requirement for Study of Drug Endangered Children Programs.
Sec. 1114. Study on drug court hearings in nontraditional places.
Sec. 1115. Report on tribal Government participation in HIDTA process.
Sec. 1116. Report on school drug testing.
Sec. 1117. Report on ONDCP performance bonuses.
Sec. 1118. Requirement for disclosure of Federal sponsorship of all 
           Federal advertising or other communication materials.
Sec. 1119. Awards for demonstration programs by local partnerships to 
           coerce abstinence in chronic hard-drug users under community 
           supervision through the use of drug testing and sanctions.
Sec. 1120. Policy relating to syringe exchange programs.

  TITLE I--ORGANIZATION OF OFFICE OF NATIONAL DRUG CONTROL POLICY AND 
                       ROLES AND RESPONSIBILITIES

SEC. 101. AMENDMENTS TO DEFINITIONS.

    (a) Demand Reduction.--Section 702(1) <<NOTE: 21 USC 1701.>> is 
amended--
            (1) in subparagraph (F), by striking ``and'' after the 
        semicolon;
            (2) in paragraph (G), by striking the period at the end and 
        inserting ``, including the testing of employees;''; and
            (3) by adding at the end the following:
                    ``(H) interventions for drug abuse and dependence;
                    ``(I) international drug control coordination and 
                cooperation with respect to activities described in this 
                paragraph; and

[[Page 120 STAT. 3504]]

                    ``(J) international drug abuse education, 
                prevention, treatment, research, rehabilitation 
                activities, and interventions for drug abuse and 
                dependence.''.

    (b) National Drug Control Program.--Section 702(6) is amended by 
adding before the period the following: ``, including any activities 
involving supply reduction, demand reduction, or State, local, and 
tribal affairs''.
    (c) Program Change.--Section 702(7) is amended by--
            (1) striking ``National Foreign Intelligence Program,'' and 
        inserting ``National Intelligence Program,''; and
            (2) inserting after ``Related Activities,'' the following: 
        ``or (for purposes of section 704(d)) an agency that is 
        described in section 530C(a) of title 28, United States Code,''.

    (d) Office.--Section 702(9) is amended by striking ``implicates'' 
and inserting ``indicates''.
    (e) State, Local, and Tribal Affairs.--Paragraph (10) of section 702 
is amended to read as follows:
            ``(10) State, local, and tribal affairs.--The term `State, 
        local, and tribal affairs' means domestic activities conducted 
        by a National Drug Control Program agency that are intended to 
        reduce the availability and use of illegal drugs, including--
                    ``(A) coordination and enhancement of Federal, 
                State, local, and tribal law enforcement drug control 
                efforts;
                    ``(B) coordination and enhancement of efforts among 
                National Drug Control Program agencies and State, local, 
                and tribal demand reduction and supply reduction 
                agencies;
                    ``(C) coordination and enhancement of Federal, 
                State, local, and tribal law enforcement initiatives to 
                gather, analyze, and disseminate information and law 
                enforcement intelligence relating to drug control among 
                domestic law enforcement agencies; and
                    ``(D) other coordinated and joint initiatives among 
                Federal, State, local, and tribal agencies to promote 
                comprehensive drug control strategies designed to reduce 
                the demand for, and the availability of, illegal 
                drugs.''.

    (f) Supply Reduction.--Section 702(11) is amended to read as 
follows:
            ``(11) Supply reduction.--The term `supply reduction' means 
        any activity or program conducted by a National Drug Control 
        Program agency that is intended to reduce the availability or 
        use of illegal drugs in the United States or abroad, including--
                    ``(A) law enforcement outside the United States;
                    ``(B) source country programs, including economic 
                development programs primarily intended to reduce the 
                production or trafficking of illicit drugs;
                    ``(C) activities to control international 
                trafficking in, and availability of, illegal drugs, 
                including--
                          ``(i) accurate assessment and monitoring of 
                      international drug production and interdiction 
                      programs and policies; and
                          ``(ii) coordination and promotion of 
                      compliance with international treaties relating to 
                      the production, transportation, or interdiction of 
                      illegal drugs;
                    ``(D) activities to conduct and promote 
                international law enforcement programs and policies to 
                reduce the supply of drugs; and

[[Page 120 STAT. 3505]]

                    ``(E) activities to facilitate and enhance the 
                sharing of domestic and foreign intelligence information 
                among National Drug Control Program agencies, relating 
                to the production and trafficking of drugs in the United 
                States and in foreign countries.''.

    (g) Definitions of Appropriate Congressional Committees and Law 
Enforcement.--Section 702 is amended by adding at the end the following:
            ``(12) Appropriate congressional committees.--Except where 
        otherwise provided, the term `appropriate congressional 
        committees' means the Committee on the Judiciary, the Committee 
        on Appropriations, and the Caucus on International Narcotics 
        Control of the Senate and the Committee on Government Reform, 
        the Committee on the Judiciary, and the Committee on 
        Appropriations of the House of Representatives.
            ``(13) Law enforcement.--The term `law enforcement' or `drug 
        law enforcement' means all efforts by a Federal, State, local, 
        or tribal government agency to enforce the drug laws of the 
        United States or any State, including investigation, arrest, 
        prosecution, and incarceration or other punishments or 
        penalties.''.
SEC. 102. ESTABLISHMENT OF THE OFFICE OF NATIONAL DRUG CONTROL 
                        POLICY.

    (a) Responsibilities.--Section 703(a) <<NOTE: 21 USC 1702.>> is 
amended to read as follows:

    ``(a) Establishment of Office.--There is established in the 
Executive Office of the President an Office of National Drug Control 
Policy, which shall--
            ``(1) develop national drug control policy;
            ``(2) coordinate and oversee the implementation of the 
        national drug control policy;
            ``(3) <<NOTE: Certification.>> assess and certify the 
        adequacy of National Drug Control Programs and the budget for 
        those programs; and
            ``(4) evaluate the effectiveness of the national drug 
        control policy and the National Drug Control Program agencies' 
        programs, by developing and applying specific goals and 
        performance measurements.''.

    (b) Positions.--Section 703(b) is amended to read as follows:
    ``(b) Director of National Drug Control Policy and Deputy 
Directors.--
            ``(1) Director.--There shall be a Director of National Drug 
        Control Policy who shall head the Office (referred to in this 
        Act as the `Director') and shall hold the same rank and status 
        as the head of an executive department listed in section 101 of 
        title 5, United States Code.
            ``(2) Deputy director.--There shall be a Deputy Director of 
        National Drug Control Policy who shall report directly to the 
        Director (referred to in this Act as the `Deputy Director').
            ``(3) Other deputy directors.--
                    ``(A) In general.--There shall be a Deputy Director 
                for Demand Reduction, a Deputy Director for Supply 
                Reduction, and a Deputy Director for State, Local, and 
                Tribal Affairs.
                    ``(B) Reporting.--The Deputy Director for Demand 
                Reduction, the Deputy Director for Supply Reduction, and 
                the Deputy Director for State, Local, and Tribal Affairs

[[Page 120 STAT. 3506]]

                shall report directly to the Deputy Director of the 
                Office of National Drug Control Policy.
                    ``(C) Deputy director for demand reduction.--The 
                Deputy Director for Demand Reduction shall be 
                responsible for the activities in subparagraphs (A) 
                through (H) of section 702(l).
                    ``(D) Deputy director for supply reduction.--The 
                Deputy Director for Supply Reduction shall--
                          ``(i) have substantial experience and 
                      expertise in drug interdiction and other supply 
                      reduction activities; and
                          ``(ii) be responsible for the activities in 
                      subparagraphs (A) through (C) in section 702(11).
                    ``(E) Deputy director for state, local, and tribal 
                affairs.--The Deputy Director for State, Local, and 
                Tribal Affairs shall be responsible for the activities--
                          ``(i) in subparagraphs (A) through (D) of 
                      section 702(10);
                          ``(ii) in section 707, the High Intensity Drug 
                      Trafficking Areas Program; and
                          ``(iii) in section 708, the Counterdrug 
                      Technology Assessment Center.''.
SEC. 103. APPOINTMENT AND RESPONSIBILITIES OF THE DIRECTOR.

    (a) Succession.--Section <<NOTE: 21 USC 1703.>> 704(a) is amended by 
amending paragraph (3) to read as follows:
            ``(3) Acting director.--If the Director dies, resigns, or is 
        otherwise unable to perform the functions and duties of the 
        office, the Deputy Director shall perform the functions and 
        duties of the Director temporarily in an acting capacity 
        pursuant to subchapter III of chapter 33 of title 5, United 
        States Code.''.

    (b) Responsibilities.--Section 704(b) is amended--
            (1) in paragraph (4), by striking ``Federal departments and 
        agencies engaged in drug enforcement'' and inserting ``National 
        Drug Control Program agencies'';
            (2) in paragraph (7), by inserting after ``President'' the 
        following: ``and the appropriate congressional committees'';
            (3) in paragraph (13), by striking ``(beginning in 1999)'';
            (4) by striking paragraph (14) and inserting the following:
            ``(14) <<NOTE: Deadline.>> shall submit to the appropriate 
        congressional committees on an annual basis, not later than 60 
        days after the date of the last day of the applicable period, a 
        summary of--
                    ``(A) each of the evaluations received by the 
                Director under paragraph (13); and
                    ``(B) the progress of each National Drug Control 
                Program agency toward the drug control program goals of 
                the agency using the performance measures for the agency 
                developed under section 706(c);'';
            (5) in paragraph (15), by striking subparagraph (C) and 
        inserting the following:
                    ``(C) supporting the substance abuse information 
                clearinghouse administered by the Administrator of the 
                Substance Abuse and Mental Health Services 
                Administration and established in section 501(d)(16) of 
                the Public Health Service Act by--

[[Page 120 STAT. 3507]]

                          ``(i) encouraging all National Drug Control 
                      Program agencies to provide all appropriate and 
                      relevant information; and
                          ``(ii) supporting the dissemination of 
                      information to all interested entities;''; and
            (6) by inserting at the end the following:
            ``(16) shall coordinate with the private sector to promote 
        private research and development of medications to treat 
        addiction;
            ``(17) shall seek the support and commitment of State, 
        local, and tribal officials in the formulation and 
        implementation of the National Drug Control Strategy;
            ``(18) shall monitor and evaluate the allocation of 
        resources among Federal law enforcement agencies in response to 
        significant local and regional drug trafficking and production 
        threats;
            ``(19) <<NOTE: Reports.>> shall submit an annual report to 
        Congress detailing how the Office of National Drug Control 
        Policy has consulted with and assisted State, local, and tribal 
        governments with respect to the formulation and implementation 
        of the National Drug Control Strategy and other relevant issues; 
        and
            ``(20) <<NOTE: Deadline. Reports.>> shall, within 1 year 
        after the date of the enactment of the Office of National Drug 
        Control Policy Reauthorization Act of 2006, report to Congress 
        on the impact of each Federal drug reduction strategy upon the 
        availability, addiction rate, use rate, and other harms of 
        illegal drugs.''.

    (c) Review and Certification of National Drug Control Program 
Budget.--Section 704(c)(3) is amended--
            (1) in subparagraph (C)(iii), by inserting ``and the 
        appropriate congressional committees,'' after ``House of 
        Representatives''; and
            (2) in subparagraph (D)(ii)(II)(bb), by inserting ``and the 
        appropriate congressional committees,'' after ``House of 
        Representatives''.

    (d) Powers of Director.--Section 704(d) is amended--
            (1) <<NOTE: Notification.>> in paragraph (9), by striking 
        ``Strategy; and'' and inserting ``Strategy and notify the 
        appropriate congressional committees of any fund control notice 
        issued in accordance with section 704(f)(5);''; and
            (2) in paragraph (10), by inserting before the period the 
        following: ``and section 706 of the Department of State 
        Authorization Act for Fiscal Year 2003 (22 U.S.C. 229j-1)''.

    (e) Fund Control Notices.--Section 704(f) is amended by adding at 
the end the following:
            ``(4) Congressional notice.--A copy of each fund control 
        notice shall be transmitted to the appropriate congressional 
        committees.
            ``(5) Restrictions.--The Director shall not issue a fund 
        control notice to direct that all or part of an amount 
        appropriated to the National Drug Control Program agency account 
        be obligated, modified, or altered in any manner--
                    ``(A) contrary, in whole or in part, to a specific 
                appropriation; or
                    ``(B) contrary, in whole or in part, to the 
                expressed intent of Congress.''.

    (f) Drug Interdiction.--
            (1) In general.--Section 711 <<NOTE: 21 USC 1710.>> is 
        amended by adding at the end the following:

[[Page 120 STAT. 3508]]

``SEC. 711. DRUG INTERDICTION COORDINATOR AND COMMITTEE.

    ``(a) United States Interdiction Coordinator.--
            ``(1) In general.--The United States Interdiction 
        Coordinator shall perform the duties of that position described 
        in paragraph (2) and such other duties as may be determined by 
        the Director with respect to coordination of efforts to 
        interdict illicit drugs from entering the United States.
            ``(2) Responsibilities.--The United States Interdiction 
        Coordinator shall be responsible to the Director for--
                    ``(A) coordinating the interdiction activities of 
                the National Drug Control Program agencies to ensure 
                consistency with the National Drug Control Strategy;
                    ``(B) <<NOTE: Deadline.>> on behalf of the Director, 
                developing and issuing, on or before March 1 of each 
                year and in accordance with paragraph (3), a National 
                Interdiction Command and Control Plan to ensure the 
                coordination and consistency described in subparagraph 
                (A);
                    ``(C) assessing the sufficiency of assets committed 
                to illicit drug interdiction by the relevant National 
                Drug Control Program agencies; and
                    ``(D) advising the Director on the efforts of each 
                National Drug Control Program agency to implement the 
                National Interdiction Command and Control Plan.
            ``(3) Staff.--The Director shall assign such permanent staff 
        of the Office as he considers appropriate to assist the United 
        States Interdiction Coordinator to carry out the 
        responsibilities described in paragraph (2), and may also, at 
        his discretion, request that appropriate National Drug Control 
        Program agencies detail or assign staff to the Office of Supply 
        Reduction for that purpose.
            ``(4) National interdiction command and control plan.--
                    ``(A) Purposes.--The National Interdiction Command 
                and Control Plan shall--
                          ``(i) set forth the Government's strategy for 
                      drug interdiction;
                          ``(ii) state the specific roles and 
                      responsibilities of the relevant National Drug 
                      Control Program agencies for implementing that 
                      strategy; and
                          ``(iii) identify the specific resources 
                      required to enable the relevant National Drug 
                      Control Program agencies to implement that 
                      strategy.
                    ``(B) Consultation with other agencies.--The United 
                States Interdiction Coordinator shall issue the National 
                Interdiction Command and Control Plan in consultation 
                with the other members of the Interdiction Committee 
                described in subsection (b).
                    ``(C) Limitation.--The National Interdiction Command 
                and Control Plan shall not change existing agency 
                authorities or the laws governing interagency 
                relationships, but may include recommendations about 
                changes to such authorities or laws.
                    ``(D) Report to congress.--On or before March 1 of 
                each year, the United States Interdiction Coordinator 
                shall provide a report on behalf of the Director to the 
                appropriate congressional committees, to the Committee

[[Page 120 STAT. 3509]]

                on Armed Services and the Committee on Homeland Security 
                of the House of Representatives, and to the Committee on 
                Homeland Security and Governmental Affairs and the 
                Committee on Armed Services of the Senate, which shall 
                include--
                          ``(i) a copy of that year's National 
                      Interdiction Command and Control Plan;
                          ``(ii) information for the previous 10 years 
                      regarding the number and type of seizures of drugs 
                      by each National Drug Control Program agency 
                      conducting drug interdiction activities, as well 
                      as statistical information on the geographic areas 
                      of such seizures; and
                          ``(iii) information for the previous 10 years 
                      regarding the number of air and maritime patrol 
                      hours undertaken by each National Drug Control 
                      Program agency conducting drug interdiction 
                      activities, as well as statistical information on 
                      the geographic areas in which such patrol hours 
                      took place.
                    ``(E) Treatment of classified or law enforcement 
                sensitive information.--Any content of the report 
                described in subparagraph (D) that involves information 
                classified under criteria established by an Executive 
                order, or the public disclosure of which, as determined 
                by the Director, the Director of National Intelligence, 
                or the head of any Federal Government agency the 
                activities of which are described in the plan, would be 
                detrimental to the law enforcement or national security 
                activities of any Federal, State, or local agency, shall 
                be presented to Congress separately from the rest of the 
                report.

    ``(b) Interdiction Committee.--
            ``(1) In general.--The Interdiction Committee shall meet 
        to--
                    ``(A) discuss and resolve issues related to the 
                coordination, oversight and integration of 
                international, border, and domestic drug interdiction 
                efforts in support of the National Drug Control 
                Strategy;
                    ``(B) review the annual National Interdiction 
                Command and Control Plan, and provide advice to the 
                Director and the United States Interdiction Coordinator 
                concerning that plan; and
                    ``(C) provide such other advice to the Director 
                concerning drug interdiction strategy and policies as 
                the committee determines is appropriate.
            ``(2) Chairman.--The Director shall designate one of the 
        members of the Interdiction Committee to serve as chairman.
            ``(3) Meetings.--The members of the Interdiction Committee 
        shall meet, in person and not through any delegate or 
        representative, at least once per calendar year, prior to March 
        1. At the call of either the Director or the current chairman, 
        the Interdiction Committee may hold additional meetings, which 
        shall be attended by the members either in person, or through 
        such delegates or representatives as they may choose.
            ``(4) Report.--Not later than September 30 of each year, the 
        chairman of the Interdiction Committee shall submit a report to 
        the Director and to the appropriate congressional

[[Page 120 STAT. 3510]]

        committees describing the results of the meetings and any 
        significant findings of the Committee during the previous 12 
        months. Any content of such a report that involves information 
        classified under criteria established by an Executive order, or 
        whose public disclosure, as determined by the Director, the 
        chairman, or any member, would be detrimental to the law 
        enforcement or national security activities of any Federal, 
        State, local, or tribal agency, shall be presented to Congress 
        separately from the rest of the report.''.
            (2) Conforming amendment to homeland security act of 2002.--
        Section 878 of the Homeland Security Act of 2002 (6 U.S.C. 458) 
        is amended--
                    (A) in subsection (c), by striking ``Except as 
                provided in subsection (d), the'' and inserting ``The''; 
                and
                    (B) by striking subsection (d) and redesignating 
                subsections (e), (f), and (g) as subsections (d), (e), 
                and (f), respectively.
            (3) Technical amendments.--Section 704 (21 U.S.C. 1703) is 
        amended--
                    (A) by amending subsection (g) to read as follows:

    ``(g) Inapplicability to Certain Programs.--The provisions of this 
section shall not apply to the National Intelligence Program, the Joint 
Military Intelligence Program, and Tactical and Related Activities, 
unless such program or an element of such program is designated as a 
National Drug Control Program--
            ``(1) by the President; or
            ``(2) jointly by--
                    ``(A) in the case of the National Intelligence 
                Program, the Director and the Director of National 
                Intelligence; or
                    ``(B) in the case of the Joint Military Intelligence 
                Program and Tactical and Related Activities, the 
                Director, the Director of National Intelligence, and the 
                Secretary of Defense.''; and
                    (B) by amending subsection (h) to read as follows:

    ``(h) Construction.--Nothing in this Act shall be construed as 
derogating the authorities and responsibilities of the Director of 
National Intelligence or the Director of the Central Intelligence Agency 
contained in the National Security Act of 1947 (50 U.S.C. 401 et seq.), 
the Central Intelligence Agency Act of 1949 (50 U.S.C. 403a et seq.), or 
any other law.''.
SEC. 104. AMENDMENTS TO ENSURE COORDINATION WITH OTHER AGENCIES.

    Section 705 <<NOTE: 21 USC 1704.>> is amended--
            (1) in subsection (a)(1)(A), by striking ``abuse'';
            (2) in subsection (a)(2)(A), by striking ``Director of 
        Central Intelligence'' and inserting ``Director of National 
        Intelligence'';
            (3) in subsection (a)(2)(B), by striking ``Director of 
        Central Intelligence'' and inserting ``Director of National 
        Intelligence and the Director of the Central Intelligence 
        Agency'';
            (4) by amending subsection (a)(3) to read as follows:
            ``(3) Required reports.--
                    ``(A) Secretaries of the interior and agriculture.--
                Not later than July 1 of each year, the Secretaries of 
                Agriculture and the Interior shall jointly submit

[[Page 120 STAT. 3511]]

                to the Director and the appropriate congressional 
                committees an assessment of the quantity of illegal drug 
                cultivation and manufacturing in the United States on 
                lands owned or under the jurisdiction of the Federal 
                Government for the preceding year.
                    ``(B) Secretary of homeland security.--Not later 
                than July 1 of each year, the Secretary of Homeland 
                Security shall submit to the Director and the 
                appropriate congressional committees information for the 
                preceding year regarding--
                          ``(i) the number and type of seizures of drugs 
                      by each component of the Department of Homeland 
                      Security seizing drugs, as well as statistical 
                      information on the geographic areas of such 
                      seizures; and
                          ``(ii) the number of air and maritime patrol 
                      hours primarily dedicated to drug supply reduction 
                      missions undertaken by each component of the 
                      Department of Homeland Security.
                    ``(C) Secretary of defense.--The Secretary of 
                Defense shall, by July 1 of each year, submit to the 
                Director and the appropriate congressional committees 
                information for the preceding year regarding the number 
                of air and maritime patrol hours primarily dedicated to 
                drug supply reduction missions undertaken by each 
                component of the Department of Defense.
                    ``(D) Attorney general.--The Attorney General shall, 
                by July 1 of each year, submit to the Director and the 
                appropriate congressional committees information for the 
                preceding year regarding the number and type of--
                          ``(i) arrests for drug violations;
                          ``(ii) prosecutions for drug violations by 
                      United States Attorneys; and
                          ``(iii) seizures of drugs by each component of 
                      the Department of Justice seizing drugs, as well 
                      as statistical information on the geographic areas 
                      of such seizures.'';
            (5) in subsection (b)(2)(B), by striking ``Program'' and 
        inserting ``Strategy''; and
            (6) in subsection (c), by striking ``in'' and inserting 
        ``on''.
SEC. 105. BUDGETARY MATTERS.

    (a) Submission of Drug Control Budget Requests.--Section 704(c)(1) 
is <<NOTE: 21 USC 1703.>> amended by adding at the end the following:
                    ``(C) Content of drug control budget requests.--A 
                drug control budget request submitted by a department, 
                agency, or program under this paragraph shall include 
                all requests for funds for any drug control activity 
                undertaken by that department, agency, or program, 
                including demand reduction, supply reduction, and State, 
                local, and tribal affairs, including any drug law 
                enforcement activities. If an activity has both drug 
                control and nondrug control purposes or applications, 
                the department, agency, or program shall estimate by a 
                documented calculation the total funds requested for 
                that activity that would be used for drug control, and 
                shall set forth in its request the basis and method for 
                making the estimate.''.

    (b) National Drug Control Budget Proposal.--

[[Page 120 STAT. 3512]]

            (1) National organizations.--Section 704(c)(2) is amended by 
        inserting ``and the head of each major national organization 
        that represents law enforcement officers, agencies, or 
        associations'' after ``agency''.
            (2) Total budget.--Section 704(c)(2)(A) is amended by 
        inserting before the semicolon: ``and to inform Congress and the 
        public about the total amount proposed to be spent on all supply 
        reduction, demand reduction, State, local, and tribal affairs, 
        including any drug law enforcement, and other drug control 
        activities by the Federal Government, which shall conform to the 
        content requirements set forth in paragraph (1)(C)''.

    (c) Review and Certification of National Drug Control Program 
Budget.--Section 704(c)(3) is amended--
            (1) by redesignating subparagraphs (C) and (D) as 
        subparagraphs (D) and (E), respectively;
            (2) by inserting after subparagraph (B) the following new 
        subparagraph:
                    ``(C) Specific requests.--The Director shall not 
                confirm the adequacy of any budget request that--
                          ``(i) requests funding for Federal law 
                      enforcement activities that do not adequately 
                      compensate for transfers of drug enforcement 
                      resources and personnel to law enforcement and 
                      investigation activities;
                          ``(ii) requests funding for law enforcement 
                      activities on the borders of the United States 
                      that do not adequately direct resources to drug 
                      interdiction and enforcement;
                          ``(iii) requests funding for drug treatment 
                      activities that do not provide adequate results 
                      and accountability measures;
                          ``(iv) requests funding for any activities of 
                      the Safe and Drug-Free Schools Program that do not 
                      include a clear anti-drug message or purpose 
                      intended to reduce drug use;
                          ``(v) requests funding for drug treatment 
                      activities that do not adequately support and 
                      enhance Federal drug treatment programs and 
                      capacity;
                          ``(vi) requests funding for fiscal year 2007 
                      for activities of the Department of Education, 
                      unless it is accompanied by a report setting forth 
                      a plan for providing expedited consideration of 
                      student loan applications for all individuals who 
                      submitted an application for any Federal grant, 
                      loan, or work assistance that was rejected or 
                      denied pursuant to 484(r)(1) of the Higher 
                      Education Act of 1965 (20 U.S.C. 1091(r)(1)) by 
                      reason of a conviction for a drug-related offense 
                      not occurring during a period of enrollment for 
                      which the individual was receiving any Federal 
                      grant, loan, or work assistance; and
                          ``(vii) requests funding for the operations 
                      and management of the Department of Homeland 
                      Security that does not include a specific request 
                      for funds for the Office of Counternarcotics 
                      Enforcement to carry out its responsibilities 
                      under section 878 of the Homeland Security Act of 
                      2002 (6 U.S.C. 458).'';

[[Page 120 STAT. 3513]]

            (3) in subparagraph (D)(iii), as so redesignated, by 
        inserting ``and the appropriate congressional committees'' after 
        ``House of Representatives''; and
            (4) in subparagraph (E)(ii)(II)(bb), as so redesignated, by 
        inserting ``and the appropriate congressional committees'' after 
        ``House of Representatives''.

    (d) Reprogramming and Transfer Requests.--Section 704(c)(4)(A) (21 
U.S.C. 1703(c)(4)(A)) is amended--
            (1) by striking ``$5,000,000'' and inserting ``$1,000,000''; 
        and
            (2) <<NOTE: Deadline.>> adding at the end the following: 
        ``If the Director has not responded to a request for 
        reprogramming subject to this subparagraph within 30 days after 
        receiving notice of the request having been made, the request 
        shall be deemed approved by the Director under this subparagraph 
        and forwarded to Congress.''.

    (e) Powers of Director.--Section 704(d) is amended--
            (1) in paragraph (8)(D), by striking ``have been authorized 
        by Congress;'' and inserting ``authorized by law;'';
            (2) in paragraph (9), by striking ``Strategy; and'' and 
        inserting ``Strategy <<NOTE: Notification.>> and notify the 
        appropriate congressional committees of any fund control notice 
        issued; and''; and
            (3) in paragraph (10), by striking ``(22 U.S.C. 2291j).'' 
        and inserting ``(22 U.S.C. 2291j) and section 706 of the Foreign 
        Relations Authorization Act, Fiscal Year 2003 (22 U.S.C. 2291j-
        1).''.

    (f) Fund Control Notices.--Section 704(f) (21 U.S.C. 1703(f)) is 
amended by adding at the end the following:
            ``(4) Congressional notice.--A copy of each fund control 
        notice shall be transmitted to the appropriate congressional 
        committees.
            ``(5) Restrictions.--The Director shall not issue a fund 
        control notice to direct that all or part of an amount 
        appropriated to the National Drug Control Program agency account 
        be obligated, modified, or altered in any manner contrary, in 
        whole or in part, to a specific appropriation or statute.''.

              TITLE II--THE NATIONAL DRUG CONTROL STRATEGY

SEC. 201. ANNUAL PREPARATION AND SUBMISSION OF NATIONAL DRUG 
                        CONTROL STRATEGY.

    Section 706 <<NOTE: 21 USC 1705.>> is amended to read as follows:
``SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, AND 
                        ASSESSMENT OF NATIONAL DRUG CONTROL 
                        STRATEGY.

    ``(a) Timing, Contents, and Process for Development and Submission 
of National Drug Control Strategy.--
            ``(1) Timing.--Not <<NOTE: President.>> later than February 
        1 of each year, the President shall submit to Congress a 
        National Drug Control Strategy, which shall set forth a 
        comprehensive plan for the year to reduce illicit drug use and 
        the consequences of such illicit drug use in the United States 
        by limiting the availability of, and reducing the demand for, 
        illegal drugs.
            ``(2) Contents.--
                    ``(A) In general.--The National Drug Control 
                Strategy submitted under paragraph (1) shall include the 
                following:

[[Page 120 STAT. 3514]]

                          ``(i) Comprehensive, research-based, long-
                      range, quantifiable goals for reducing illicit 
                      drug use and the consequences of illicit drug use 
                      in the United States.
                          ``(ii) Annual quantifiable and measurable 
                      objectives and specific targets to accomplish 
                      long-term quantifiable goals that the Director 
                      determines may be achieved during each year 
                      beginning on the date on which the National Drug 
                      Control Strategy is submitted.
                          ``(iii) A 5-year projection for program and 
                      budget priorities.
                          ``(iv) A review of international, State, 
                      local, and private sector drug control activities 
                      to ensure that the United States pursues 
                      coordinated and effective drug control at all 
                      levels of government.
                          ``(v) An assessment of current illicit drug 
                      use (including inhalants and steroids) and 
                      availability, impact of illicit drug use, and 
                      treatment availability, which assessment shall 
                      include--
                                    ``(I) estimates of drug prevalence 
                                and frequency of use as measured by 
                                national, State, and local surveys of 
                                illicit drug use and by other special 
                                studies of nondependent and dependent 
                                illicit drug use;
                                    ``(II) illicit drug use in the 
                                workplace and the productivity lost by 
                                such use; and
                                    ``(III) illicit drug use by 
                                arrestees, probationers, and parolees.
                          ``(vi) An assessment of the reduction of 
                      illicit drug availability, as measured by--
                                    ``(I) the quantities of cocaine, 
                                heroin, marijuana, methamphetamine, 
                                ecstasy, and other drugs available for 
                                consumption in the United States;
                                    ``(II) the amount of marijuana, 
                                cocaine, heroin, methamphetamine, 
                                ecstasy, and precursor chemicals and 
                                other drugs entering the United States;
                                    ``(III) the number of illicit drug 
                                manufacturing laboratories seized and 
                                destroyed and the number of hectares of 
                                marijuana, poppy, and coca cultivated 
                                and destroyed domestically and in other 
                                countries;
                                    ``(IV) the number of metric tons of 
                                marijuana, heroin, cocaine, and 
                                methamphetamine seized and other drugs; 
                                and
                                    ``(V) changes in the price and 
                                purity of heroin, methamphetamine, and 
                                cocaine, changes in the price of 
                                ecstasy, and changes in 
                                tetrahydrocannabinol level of marijuana 
                                and other drugs.
                          ``(vii) An assessment of the reduction of the 
                      consequences of illicit drug use and availability, 
                      which shall include--
                                    ``(I) the burden illicit drug users 
                                placed on hospital emergency departments 
                                in the United States, such as the 
                                quantity of illicit drug-related 
                                services provided;

[[Page 120 STAT. 3515]]

                                    ``(II) the annual national health 
                                care cost of illicit drug use; and
                                    ``(III) the extent of illicit drug-
                                related crime and criminal activity.
                          ``(viii) A determination of the status of drug 
                      treatment in the United States, by assessing--
                                    ``(I) public and private treatment 
                                utilization; and
                                    ``(II) the number of illicit drug 
                                users the Director estimates meet 
                                diagnostic criteria for treatment.
                          ``(ix) A review of the research agenda of the 
                      Counterdrug Technology Assessment Center to reduce 
                      the availability and abuse of drugs.
                          ``(x) A summary of the efforts made to 
                      coordinate with private sector entities to conduct 
                      private research and development of medications to 
                      treat addiction by--
                                    ``(I) screening chemicals for 
                                potential therapeutic value;
                                    ``(II) developing promising 
                                compounds;
                                    ``(III) conducting clinical trials;
                                    ``(IV) seeking Food and Drug 
                                Administration approval for drugs to 
                                treat addiction;
                                    ``(V) marketing the drug for the 
                                treatment of addiction;
                                    ``(VI) urging physicians to use the 
                                drug in the treatment of addiction; and
                                    ``(VII) encouraging insurance 
                                companies to reimburse the cost of the 
                                drug for the treatment of addiction.
                          ``(xi) An assessment of Federal effectiveness 
                      in achieving the National Drug Control Strategy 
                      for the previous year, including a specific 
                      evaluation of whether the objectives and targets 
                      for reducing illicit drug use for the previous 
                      year were met and reasons for the success or 
                      failure of the previous year's Strategy.
                          ``(xii) A general review of the status of, and 
                      trends in, demand reduction activities by private 
                      sector entities and community-based organizations, 
                      including faith-based organizations, to determine 
                      their effectiveness and the extent of cooperation, 
                      coordination, and mutual support between such 
                      entities and organizations and Federal, State, 
                      local, and tribal government agencies.
                          ``(xiii) Such additional statistical data and 
                      information as the Director considers appropriate 
                      to demonstrate and assess trends relating to 
                      illicit drug use, the effects and consequences of 
                      illicit drug use (including the effects on 
                      children of substance abusers), supply reduction, 
                      demand reduction, drug-related law enforcement, 
                      and the implementation of the National Drug 
                      Control Strategy.
                          ``(xiv) A supplement reviewing the activities 
                      of each individual National Drug Control Program 
                      agency during the previous year with respect to 
                      the National Drug Control Strategy and the 
                      Director's assessment

[[Page 120 STAT. 3516]]

                      of the progress of each National Drug Control 
                      Program agency in meeting its responsibilities 
                      under the National Drug Control Strategy.
                    ``(B) Classified information.--Any contents of the 
                National Drug Control Strategy that involve information 
                properly classified under criteria established by an 
                Executive order shall be presented to Congress 
                separately from the rest of the National Drug Control 
                Strategy.
                    ``(C) Selection of data and information.--In 
                selecting data and information for inclusion under 
                subparagraph (A), the Director shall ensure--
                          ``(i) the inclusion of data and information 
                      that will permit analysis of current trends 
                      against previously compiled data and information 
                      where the Director believes such analysis enhances 
                      long-term assessment of the National Drug Control 
                      Strategy; and
                          ``(ii) the inclusion of data and information 
                      to permit a standardized and uniform assessment of 
                      the effectiveness of drug treatment programs in 
                      the United States.
            ``(3) Process for development and submission.--In developing 
        and effectively implementing the National Drug Control Strategy, 
        the Director--
                    ``(A) shall consult with--
                          ``(i) the heads of the National Drug Control 
                      Program agencies;
                          ``(ii) Congress;
                          ``(iii) State, local, and tribal officials;
                          ``(iv) private citizens and organizations, 
                      including community and faith-based organizations 
                      with experience and expertise in demand reduction;
                          ``(v) private citizens and organizations with 
                      experience and expertise in supply reduction; and
                          ``(vi) appropriate representatives of foreign 
                      governments;
                    ``(B) in satisfying the requirements of subparagraph 
                (A), shall ensure, to the maximum extent possible, that 
                State, local, and tribal officials and relevant private 
                organizations commit to support and take steps to 
                achieve the goals and objectives of the National Drug 
                Control Strategy;
                    ``(C) with the concurrence of the Attorney General, 
                may require the El Paso Intelligence Center to undertake 
                specific tasks or projects to support or implement the 
                National Drug Control Strategy; and
                    ``(D) with the concurrence of the Director of 
                National Intelligence and the Attorney General, may 
                request that the National Drug Intelligence Center 
                undertake specific tasks or projects to support or 
                implement the National Drug Control Strategy.

    ``(b) Submission of Revised Strategy.--The President may submit to 
Congress a revised National Drug Control Strategy that meets the 
requirements of this section--
            ``(1) at any time, upon a determination of the President, in 
        consultation with the Director, that the National Drug Control 
        Strategy in effect is not sufficiently effective; or
            ``(2) if a new President or Director takes office.''.

[[Page 120 STAT. 3517]]

SEC. 202. PERFORMANCE MEASUREMENTS.

    Section 706 <<NOTE: Deadline.>> is amended by adding at the end the 
following:
    ``(c) Performance Measurement System.--Not later than February 1 of 
each year, the Director shall submit to Congress as part of the National 
Drug Control Strategy, a description of a national drug control 
performance measurement system, that--
            ``(1) develops 2-year and 5-year performance measures and 
        targets for each National Drug Control Strategy goal and 
        objective established for reducing drug use, availability, and 
        the consequences of drug use;
            ``(2) describes the sources of information and data that 
        will be used for each performance measure incorporated into the 
        performance measurement system;
            ``(3) identifies major programs and activities of the 
        National Drug Control Program agencies that support the goals 
        and annual objectives of the National Drug Control Strategy;
            ``(4) evaluates the contribution of demand reduction and 
        supply reduction activities as defined in section 702 
        implemented by each National Drug Control Program agency in 
        support of the National Drug Control Strategy;
            ``(5) monitors consistency between the drug-related goals 
        and objectives of the National Drug Control Program agencies and 
        ensures that each agency's goals and budgets support and are 
        fully consistent with the National Drug Control Strategy; and
            ``(6) coordinates the development and implementation of 
        national drug control data collection and reporting systems to 
        support policy formulation and performance measurement, 
        including an assessment of--
                    ``(A) the quality of current drug use measurement 
                instruments and techniques to measure supply reduction 
                and demand reduction activities;
                    ``(B) the adequacy of the coverage of existing 
                national drug use measurement instruments and techniques 
                to measure the illicit drug user population, and groups 
                that are at risk for illicit drug use;
                    ``(C) the adequacy of the coverage of existing 
                national treatment outcome monitoring systems to measure 
                the effectiveness of drug abuse treatment in reducing 
                illicit drug use and criminal behavior during and after 
                the completion of substance abuse treatment; and
                    ``(D) the actions the Director shall take to correct 
                any deficiencies and limitations identified pursuant to 
                subparagraphs (A) and (B) of this subsection.

    ``(d) Modifications.--A description of any modifications made during 
the preceding year to the national drug performance measurement system 
described in subsection (c) shall be included in each report submitted 
under subsection (b).''.
SEC. 203. <<NOTE: 21 USC 1708a.>> ANNUAL REPORT REQUIREMENT.

    (a) In General.--On or before February 1 of each year, the Director 
shall submit a report to Congress that describes--
            (1) the strategy of the national media campaign and whether 
        specific objectives of the campaign were accomplished;
            (2) steps taken to ensure that the national media campaign 
        operates in an effective and efficient manner consistent with 
        the overall strategy and focus of the campaign;

[[Page 120 STAT. 3518]]

            (3) plans to purchase advertising time and space;
            (4) policies and practices implemented to ensure that 
        Federal funds are used responsibly to purchase advertising time 
        and space and eliminate the potential for waste, fraud, and 
        abuse;
            (5) all contracts entered into with a corporation, 
        partnership, or individual working on behalf of the national 
        media campaign;
            (6) specific policies and steps implemented to ensure 
        compliance with title IV of this Act;
            (7) steps taken to ensure that the national media campaign 
        will secure, to the maximum extent possible, no cost matches of 
        advertising time and space or in-kind contributions that are 
        directly related to the campaign in accordance with title IV of 
        this Act; and
            (8) a review and evaluation of the effectiveness of the 
        national media campaign strategy for the past year.

    (b) Audit.--The Government Accountability Office shall, at a 
frequency of not less than once per year--
            (1) conduct and supervise an audit and investigation 
        relating to the programs and operations of the--
                    (A) Office; or
                    (B) certain programs within the Office, including--
                          (i) the High Intensity Drug Trafficking Areas 
                      Program;
                          (ii) the Counterdrug Technology Assessment 
                      Center; or
                          (iii) the National Youth Anti-drug Media 
                      Campaign; and
            (2) provide the Director and the appropriate congressional 
        committees with a report containing an evaluation of and 
        recommendations on the--
                    (A) policies and activities of the programs and 
                operations subject to the audit and investigation;
                    (B) economy, efficiency, and effectiveness in the 
                administration of the reviewed programs and operations; 
                and
                    (C) policy or management changes needed to prevent 
                and detect fraud and abuse in such programs and 
                operations.

            TITLE III--HIGH INTENSITY DRUG TRAFFICKING AREAS

SEC. 301. HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM.

    Section 707 <<NOTE: 21 USC 1706.>> is amended to read as follows:
``SEC. 707. HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM.

    ``(a) Establishment.--
            ``(1) In general.--There is established in the Office a 
        program to be known as the High Intensity Drug Trafficking Areas 
        Program (in this section referred to as the `Program').
            ``(2) Purpose.--The purpose of the Program is to reduce drug 
        trafficking and drug production in the United States by--

[[Page 120 STAT. 3519]]

                    ``(A) facilitating cooperation among Federal, State, 
                local, and tribal law enforcement agencies to share 
                information and implement coordinated enforcement 
                activities;
                    ``(B) enhancing law enforcement intelligence sharing 
                among Federal, State, local, and tribal law enforcement 
                agencies;
                    ``(C) providing reliable law enforcement 
                intelligence to law enforcement agencies needed to 
                design effective enforcement strategies and operations; 
                and
                    ``(D) supporting coordinated law enforcement 
                strategies which maximize use of available resources to 
                reduce the supply of illegal drugs in designated areas 
                and in the United States as a whole.

    ``(b) Designation.--
            ``(1) In general.--The Director, in consultation with the 
        Attorney General, the Secretary of the Treasury, the Secretary 
        of Homeland Security, heads of the National Drug Control Program 
        agencies, and the Governor of each applicable State, may 
        designate any specified area of the United States as a high 
        intensity drug trafficking area.
            ``(2) Activities.--After making a designation under 
        paragraph (1) and in order to provide Federal assistance to the 
        area so designated, the Director may--
                    ``(A) obligate such sums as are appropriated for the 
                Program;
                    ``(B) direct the temporary reassignment of Federal 
                personnel to such area, subject to the approval of the 
                head of the department or agency that employs such 
                personnel;
                    ``(C) take any other action authorized under section 
                704 to provide increased Federal assistance to those 
                areas; and
                    ``(D) coordinate activities under this section 
                (specifically administrative, recordkeeping, and funds 
                management activities) with State, local, and tribal 
                officials.

    ``(c) Petitions for Designation.--
The <<NOTE: Regulations.>> Director shall establish regulations under 
which a coalition of interested law enforcement agencies from an area 
may petition for designation as a high intensity drug trafficking area. 
Such regulations shall provide for a regular review by the Director of 
the petition, including a recommendation regarding the merit of the 
petition to the Director by a panel of qualified, independent experts.

    ``(d) Factors for Consideration.--In considering whether to 
designate an area under this section as a high intensity drug 
trafficking area, the Director shall consider, in addition to such other 
criteria as the Director considers to be appropriate, the extent to 
which--
            ``(1) the area is a significant center of illegal drug 
        production, manufacturing, importation, or distribution;
            ``(2) State, local, and tribal law enforcement agencies have 
        committed resources to respond to the drug trafficking problem 
        in the area, thereby indicating a determination to respond 
        aggressively to the problem;
            ``(3) drug-related activities in the area are having a 
        significant harmful impact in the area, and in other areas of 
        the country; and

[[Page 120 STAT. 3520]]

            ``(4) a significant increase in allocation of Federal 
        resources is necessary to respond adequately to drug-related 
        activities in the area.

    ``(e) Organization of High Intensity Drug Trafficking Areas.--
            ``(1) Executive <<NOTE: Establishment.>> board and 
        officers.--To be eligible for funds appropriated under this 
        section, each high intensity drug trafficking area shall be 
        governed by an Executive Board. The Executive Board shall 
        designate a chairman, vice chairman, and any other officers to 
        the Executive Board that it determines are necessary.
            ``(2) Responsibilities.--The Executive Board of a high 
        intensity drug trafficking area shall be responsible for--
                    ``(A) providing direction and oversight in 
                establishing and achieving the goals of the high 
                intensity drug trafficking area;
                    ``(B) managing the funds of the high intensity drug 
                trafficking area;
                    ``(C) reviewing and approving all funding proposals 
                consistent with the overall objective of the high 
                intensity drug trafficking area; and
                    ``(D) reviewing and approving all reports to the 
                Director on the activities of the high intensity drug 
                trafficking area.
            ``(3) Board representation.--None of the funds appropriated 
        under this section may be expended for any high intensity drug 
        trafficking area, or for a partnership or region of a high 
        intensity drug trafficking area, if the Executive Board for such 
        area, region, or partnership, does not apportion an equal number 
        of votes between representatives of participating Federal 
        agencies and representatives of participating State, local, and 
        tribal agencies. Where it is impractical for an equal number of 
        representatives of Federal agencies and State, local, and tribal 
        agencies to attend a meeting of an Executive Board in person, 
        the Executive Board may use a system of proxy votes or weighted 
        votes to achieve the voting balance required by this paragraph.
            ``(4) No agency relationship.--The eligibility requirements 
        of this section are intended to ensure the responsible use of 
        Federal funds. Nothing in this section is intended to create an 
        agency relationship between individual high intensity drug 
        trafficking areas and the Federal Government.

    ``(f) Use of Funds.--The Director shall ensure that no Federal funds 
appropriated for the Program are expended for the establishment or 
expansion of drug treatment programs, and shall ensure that not more 
than 5 percent of the Federal funds appropriated for the Program are 
expended for the establishment of drug prevention programs.
    ``(g) Counterterrorism Activities.--
            ``(1) Assistance authorized.--The Director may authorize use 
        of resources available for the Program to assist Federal, State, 
        local, and tribal law enforcement agencies in investigations and 
        activities related to terrorism and prevention of terrorism, 
        especially but not exclusively with respect to such 
        investigations and activities that are also related to drug 
        trafficking.
            ``(2) Limitation.--The Director shall ensure--
                    ``(A) that assistance provided under paragraph (1) 
                remains incidental to the purpose of the Program to 
                reduce

[[Page 120 STAT. 3521]]

                drug availability and carry out drug-related law 
                enforcement activities; and
                    ``(B) that significant resources of the Program are 
                not redirected to activities exclusively related to 
                terrorism, except on a temporary basis under 
                extraordinary circumstances, as determined by the 
                Director.

    ``(h) Role of Drug Enforcement Administration.--The Director, in 
consultation with the Attorney General, shall ensure that a 
representative of the Drug Enforcement Administration is included in the 
Intelligence Support Center for each high intensity drug trafficking 
area.
    ``(i) Annual HIDTA Program Budget Submissions.--As part of the 
documentation that supports the President's annual budget request for 
the Office, the Director shall submit to Congress a budget justification 
that includes--
            ``(1) the amount proposed for each high intensity drug 
        trafficking area, conditional upon a review by the Office of the 
        request submitted by the HIDTA and the performance of the HIDTA, 
        with supporting narrative descriptions and rationale for each 
        request;
            ``(2) a detailed justification that explains--
                    ``(A) the reasons for the proposed funding level; 
                how such funding level was determined based on a current 
                assessment of the drug trafficking threat in each high 
                intensity drug trafficking area;
                    ``(B) how such funding will ensure that the goals 
                and objectives of each such area will be achieved; and
                    ``(C) how such funding supports the National Drug 
                Control Strategy; and
            ``(3) the amount of HIDTA funds used to investigate and 
        prosecute organizations and individuals trafficking in 
        methamphetamine in the prior calendar year, and a description of 
        how those funds were used.

    ``(j) Emerging Threat Response Fund.--
            ``(1) In general.--Subject to the availability of 
        appropriations, the Director may expend up to 10 percent of the 
        amounts appropriated under this section on a discretionary 
        basis, to respond to any emerging drug trafficking threat in an 
        existing high intensity drug trafficking area, or to establish a 
        new high intensity drug trafficking area or expand an existing 
        high intensity drug trafficking area, in accordance with the 
        criteria established under paragraph (2).
            ``(2) Consideration of impact.--In allocating funds under 
        this subsection, the Director shall consider--
                    ``(A) the impact of activities funded on reducing 
                overall drug traffic in the United States, or minimizing 
                the probability that an emerging drug trafficking threat 
                will spread to other areas of the United States; and
                    ``(B) such other criteria as the Director considers 
                appropriate.

    ``(k) Evaluation.--
            ``(1) Initial report.--Not later than 90 days after the date 
        of the enactment of this section, the Director shall, after 
        consulting with the Executive Boards of each designated high 
        intensity drug trafficking area, submit a report to Congress 
        that describes, for each designated high intensity drug 
        trafficking area--

[[Page 120 STAT. 3522]]

                    ``(A) the specific purposes for the high intensity 
                drug trafficking area;
                    ``(B) the specific long-term and short-term goals 
                and objectives for the high intensity drug trafficking 
                area;
                    ``(C) the measurements that will be used to evaluate 
                the performance of the high intensity drug trafficking 
                area in achieving the long-term and short-term goals; 
                and
                    ``(D) the reporting requirements needed to evaluate 
                the performance of the high intensity drug trafficking 
                area in achieving the long-term and short-term goals.
            ``(2) Evaluation <<NOTE: Reports.>> of hidta program as part 
        of national drug control strategy.--For each designated high 
        intensity drug trafficking area, the Director shall submit, as 
        part of the annual National Drug Control Strategy report, a 
        report that--
                    ``(A) describes--
                          ``(i) the specific purposes for the high 
                      intensity drug trafficking area; and
                          ``(ii) the specific long-term and short-term 
                      goals and objectives for the high intensity drug 
                      trafficking area; and
                    ``(B) includes an evaluation of the performance of 
                the high intensity drug trafficking area in 
                accomplishing the specific long-term and short-term 
                goals and objectives identified under paragraph (1)(B).

    ``(l) Assessment <<NOTE: Deadline. Reports.>> of Drug Enforcement 
Task Forces in High Intensity Drug Trafficking Areas.--Not later than 1 
year after the date of enactment of this subsection, and as part of each 
subsequent annual National Drug Control Strategy report, the Director 
shall submit to Congress a report--
            ``(1) assessing the number and operation of all federally 
        funded drug enforcement task forces within each high intensity 
        drug trafficking area; and
            ``(2) describing--
                    ``(A) each Federal, State, local, and tribal drug 
                enforcement task force operating in the high intensity 
                drug trafficking area;
                    ``(B) how such task forces coordinate with each 
                other, with any high intensity drug trafficking area 
                task force, and with investigations receiving funds from 
                the Organized Crime and Drug Enforcement Task Force;
                    ``(C) what steps, if any, each such task force takes 
                to share information regarding drug trafficking and drug 
                production with other federally funded drug enforcement 
                task forces in the high intensity drug trafficking area;
                    ``(D) the role of the high intensity drug 
                trafficking area in coordinating the sharing of such 
                information among task forces;
                    ``(E) the nature and extent of cooperation by each 
                Federal, State, local, and tribal participant in 
                ensuring that such information is shared among law 
                enforcement agencies and with the high intensity drug 
                trafficking area;
                    ``(F) the nature and extent to which information 
                sharing and enforcement activities are coordinated with 
                joint terrorism task forces in the high intensity drug 
                trafficking area; and

[[Page 120 STAT. 3523]]

                    ``(G) any recommendations for measures needed to 
                ensure that task force resources are utilized 
                efficiently and effectively to reduce the availability 
                of illegal drugs in the high intensity drug trafficking 
                areas.

    ``(m) Assessment <<NOTE: Deadline. Reports.>> of Law Enforcement 
Intelligence Sharing in High Intensity Drug Trafficking Areas Program.--
Not later than 180 days after the date of the enactment of this section, 
and as part of each subsequent annual National Drug Control Strategy 
report, the Director, in consultation with the Director of National 
Intelligence, shall submit to Congress a report--
            ``(1) evaluating existing and planned law enforcement 
        intelligence systems supported by each high intensity drug 
        trafficking area, or utilized by task forces receiving any 
        funding under the Program, including the extent to which such 
        systems ensure access and availability of law enforcement 
        intelligence to Federal, State, local, and tribal law 
        enforcement agencies within the high intensity drug trafficking 
        area and outside of it;
            ``(2) the extent to which Federal, State, local, and tribal 
        law enforcement agencies participating in each high intensity 
        drug trafficking area are sharing law enforcement intelligence 
        information to assess current drug trafficking threats and 
        design appropriate enforcement strategies; and
            ``(3) the measures needed to improve effective sharing of 
        information and law enforcement intelligence regarding drug 
        trafficking and drug production among Federal, State, local, and 
        tribal law enforcement participating in a high intensity drug 
        trafficking area, and between such agencies and similar agencies 
        outside the high intensity drug trafficking area.

    ``(n) Coordination of Law Enforcement Intelligence Sharing With 
Organized Crime Drug Enforcement Task Force Program.--The Director, in 
consultation with the Attorney General, shall ensure that any drug 
enforcement intelligence obtained by the Intelligence Support Center for 
each high intensity drug trafficking area is shared, on a timely basis, 
with the drug intelligence fusion center operated by the Organized Crime 
Drug Enforcement Task Force of the Department of Justice.
    ``(o) Use of Funds To Combat Methamphetamine Trafficking.--
            ``(1) Requirement.--As <<NOTE: Reports.>> part of the 
        documentation that supports the President's annual budget 
        request for the Office, the Director shall submit to Congress a 
        report describing the use of HIDTA funds to investigate and 
        prosecute organizations and individuals trafficking in 
        methamphetamine in the prior calendar year.
            ``(2) Contents.--The report shall include--
                    ``(A) the number of methamphetamine manufacturing 
                facilities discovered through HIDTA-funded initiatives 
                in the previous fiscal year;
                    ``(B) the amounts of methamphetamine or listed 
                chemicals (as that term is defined in section 102(33) of 
                the Controlled Substances Act (21 U.S.C. 802(33)) seized 
                by HIDTA-funded initiatives in the area during the 
                previous year; and

[[Page 120 STAT. 3524]]

                    ``(C) law enforcement intelligence and predictive 
                data from the Drug Enforcement Administration showing 
                patterns and trends in abuse, trafficking, and 
                transportation in methamphetamine and listed chemicals.
            ``(3) Certification.--Before the Director awards any funds 
        to a high intensity drug trafficking area, the Director shall 
        certify that the law enforcement entities participating in that 
        HIDTA are providing laboratory seizure data to the national 
        clandestine laboratory database at the El Paso Intelligence 
        Center.

    ``(p) Authorization of Appropriations.--There is authorized to be 
appropriated to the Office of National Drug Control Policy to carry out 
this section--
            ``(1) $240,000,000 for fiscal year 2007;
            ``(2) $250,000,000 for fiscal year 2008;
            ``(3) $260,000,000 for fiscal year 2009;
            ``(4) $270,000,000 for fiscal year 2010; and
            ``(5) $280,000,000 for each of fiscal year 2011.''.
SEC. 302. <<NOTE: Dawson Family Community Protection Act. 21 USC 
                        1701 note.>> FUNDING FOR CERTAIN HIGH 
                        INTENSITY DRUG TRAFFICKING AREAS.

    (a) Short Title.--This section may be cited as the ``Dawson Family 
Community Protection Act''.
    (b) Findings.--Congress <<NOTE: Carnell Dawson. Angela Dawson. 21 
USC 1706 note.>> finds the following:
            (1) In the early morning hours of October 16, 2002, the home 
        of Carnell and Angela Dawson was firebombed in apparent 
        retaliation for Mrs. Dawson's notification to police about 
        persistent drug distribution activity in their East Baltimore 
        City neighborhood.
            (2) The arson claimed the lives of Mr. and Mrs. Dawson and 
        their 5 young children, aged 9 to 14.
            (3) The horrific murder of the Dawson family is a stark 
        example of domestic narco-terrorism.
            (4) In all phases of counternarcotics law enforcement--from 
        prevention to investigation to prosecution to reentry--the 
        voluntary cooperation of ordinary citizens is a critical 
        component.
            (5) Voluntary cooperation is difficult for law enforcement 
        officials to obtain when citizens feel that cooperation carries 
        the risk of violent retaliation by illegal drug trafficking 
        organizations and their affiliates.
            (6) Public confidence that law enforcement is doing all it 
        can to make communities safe is a prerequisite for voluntary 
        cooperation among people who may be subject to intimidation or 
        reprisal (or both).
            (7) Witness protection programs are insufficient on their 
        own to provide security because many individuals and families 
        who strive every day to make distressed neighborhoods livable 
        for their children, other relatives, and neighbors will resist 
        or refuse offers of relocation by local, State, and Federal 
        prosecutorial agencies and because, moreover, the continued 
        presence of strong individuals and families is critical to 
        preserving and strengthening the social fabric in such 
        communities.
            (8) Where (as in certain sections of Baltimore City) 
        interstate trafficking of illegal drugs has severe ancillary 
        local consequences within areas designated as high intensity 
        drug trafficking areas, it is important that supplementary High 
        Intensity

[[Page 120 STAT. 3525]]

        Drug Trafficking Areas Program funds be committed to support 
        initiatives aimed at making the affected communities safe for 
        the residents of those communities and encouraging their 
        cooperation with tribal, local, State, and Federal law 
        enforcement efforts to combat illegal drug trafficking.

    (c) Funding for Certain High Intensity Drug Trafficking Areas.--
Section 707, as amended by section 301, is amended by adding at the end 
the following:
    ``(q) Specific Purposes.--
            ``(1) In general.--The Director shall ensure that, of the 
        amounts appropriated for a fiscal year for the Program, at least 
        $7,000,000 is used in high intensity drug trafficking areas with 
        severe neighborhood safety and illegal drug distribution 
        problems.
            ``(2) Required uses.--The funds used under paragraph (1) 
        shall be used--
                    ``(A) to ensure the safety of neighborhoods and the 
                protection of communities, including the prevention of 
                the intimidation of potential witnesses of illegal drug 
                distribution and related activities; and
                    ``(B) to combat illegal drug trafficking through 
                such methods as the Director considers appropriate, such 
                as establishing or operating (or both) a toll-free 
                telephone hotline for use by the public to provide 
                information about illegal drug-related activities.''.
SEC. 303. <<NOTE: New York. New Jersey.>> ASSESSMENT.

    The Director shall assess the ability of the HIDTA Program to 
respond to the so-called ``balloon effect'', whereby urban drug 
traffickers facing intensive law enforcement efforts expand and spread 
their trafficking and distribution into rural, suburban, and smaller 
urban areas by conducting a demonstration project examining the ability 
of the New York/New Jersey HIDTA, with its new single colocated 
Organized Crime and Drug Enforcement Task Force/High Intensity Drug 
Trafficking Area Strike Force and HIDTA Regional Intelligence Center, to 
address the movement of drug traffickers into the more rural, suburban, 
and smaller areas encompassed by the counties of Albany, Onondaga, 
Monroe, and Erie in New York State and by annexing these counties into 
the existing New York/New Jersey HIDTA.

                          TITLE IV--TECHNOLOGY

SEC. 401. COUNTERDRUG TECHNOLOGY ASSESSMENT CENTER.

    (a) Chief Scientist.--Section <<NOTE: 21 USC 1707.>> 708(b) is 
amended to read as follows:

    ``(b) Chief Scientist.--There shall be at the head of the Center the 
Chief Scientist, who shall be appointed by the Director from among 
individuals qualified and distinguished in the area of science, 
medicine, engineering, or technology.''.
    (b) Responsibilities.--
            (1) Research and development.--Section 708 is amended by--
                    (A) redesignating subsection (d) as subsection (e); 
                and
                    (B) striking subsection (c) and inserting the 
                following:

[[Page 120 STAT. 3526]]

    ``(c) Research and Development Responsibilities.--The Director, 
acting through the Chief Scientist, shall--
            ``(1) identify and define the short-, medium-, and long-term 
        scientific and technological needs of Federal, State, local, and 
        tribal drug supply reduction agencies, including--
                    ``(A) advanced surveillance, tracking, and radar 
                imaging;
                    ``(B) electronic support measures;
                    ``(C) communications;
                    ``(D) data fusion, advanced computer systems, and 
                artificial intelligence; and
                    ``(E) chemical, biological, radiological (including 
                neutron and electron), and other means of detection;
            ``(2) identify demand reduction basic and applied research 
        needs and initiatives, in consultation with affected National 
        Drug Control Program agencies, including--
                    ``(A) improving treatment through neuroscientific 
                advances;
                    ``(B) improving the transfer of biomedical research 
                to the clinical setting; and
                    ``(C) in consultation with the National Institute of 
                Drug Abuse and the Substance Abuse and Mental Health 
                Services Administration, and through interagency 
                agreements or grants, examining addiction and 
                rehabilitation research and the application of 
                technology to expanding the effectiveness and 
                availability of drug treatment;
            ``(3) make a priority ranking of such needs identified in 
        paragraphs (1) and (2) according to fiscal and technological 
        feasibility, as part of a National Counterdrug Research and 
        Development Program;
            ``(4) oversee and coordinate counterdrug technology 
        initiatives with related activities of other Federal civilian 
        and military departments;
            ``(5) provide support to the development and implementation 
        of the national drug control performance measurement system 
        established under subsection (c) of section 706; and
            ``(6) pursuant to the authority of the Director of National 
        Drug Control Policy under section 704, submit requests to 
        Congress for the reprogramming or transfer of funds appropriated 
        for counterdrug technology research and development.

    ``(d) Limitation on Authority.--The authority granted to the 
Director under this section shall not extend to the awarding of 
contracts, management of individual projects, or other operational 
activities.''.
            (2) Assistance and support.--Subsection (e) of section 708, 
        as redesignated by this section, is amended to read as follows:

    ``(e) Assistance and Support to the Office of National Drug Control 
Policy.--The Secretary of Defense, the Secretary of Homeland Security, 
and the Secretary of Health and Human Services shall, to the maximum 
extent practicable, render assistance and support to the Office and to 
the Director in the conduct of counterdrug technology assessment.''.
            (3) Technology transfer program.--Section 708 is amended by 
        adding at the end the following:

    ``(f) Technology Transfer Program.--

[[Page 120 STAT. 3527]]

            ``(1) Program.--The Chief Scientist, with the advice and 
        counsel of experts from State, local, and tribal law enforcement 
        agencies, shall be responsible to the Director for coordination 
        and implementation of a counterdrug technology transfer program.
            ``(2) Purpose.--The purpose of the Technology Transfer 
        Program shall be for the Counterdrug Technology Assessment 
        Center to transfer technology and associated training directly 
        to State, local, and tribal law enforcement agencies.
            ``(3) Priority of receipts.--Transfers shall be made in 
        priority order based on--
                    ``(A) the need of potential recipients for such 
                technology;
                    ``(B) the effectiveness of the technology to enhance 
                current counterdrug activities of potential recipients; 
                and
                    ``(C) the ability and willingness of potential 
                recipients to evaluate transferred technology.
            ``(4) Agreement authority.--The Director may enter into an 
        agreement with the Secretary of Homeland Security to transfer 
        technology with both counterdrug and homeland security 
        applications to State, local, and tribal law enforcement 
        agencies on a reimbursable basis.
            ``(5) Report.--On or before July 1 of each year, the 
        Director shall submit a report to the appropriate congressional 
        committees that addresses the following:
                    ``(A) The number of requests received during the 
                previous 12 months, including the identity of each 
                requesting agency and the type of technology requested.
                    ``(B) The number of requests fulfilled during the 
                previous 12 months, including the identity of each 
                recipient agency and the type of technology transferred.
                    ``(C) A summary of the criteria used in making the 
                determination on what requests were funded and what 
                requests were not funded, except that such summary shall 
                not include specific information on any individual 
                requests.
                    ``(D) A general assessment of the future needs of 
                the program, based on expected changes in threats, 
                expected technologies, and likely need from potential 
                recipients.
                    ``(E) An assessment of the effectiveness of the 
                technologies transferred, based in part on the 
                evaluations provided by the recipients, with a 
                recommendation whether the technology should continue to 
                be offered through the program.''.

    (c) Assistance From Secretary of Homeland Security.--Section 708(d) 
(21 U.S.C. 1707(d)) is amended by inserting ``, the Secretary of 
Homeland Security,'' after ``The Secretary of Defense''.

                 TITLE V--NATIONAL YOUTH MEDIA CAMPAIGN

SEC. 501. NATIONAL YOUTH ANTI-DRUG MEDIA CAMPAIGN.

    (a) In General.--Section 709 (21 U.S.C. 1708) is amended to read as 
follows:

[[Page 120 STAT. 3528]]

``SEC. 709. NATIONAL YOUTH ANTI-DRUG MEDIA CAMPAIGN.

    ``(a) In General.--The Director shall conduct a national youth anti-
drug media campaign (referred to in this subtitle as the `national media 
campaign') in accordance with this section for the purposes of--
            ``(1) preventing drug abuse among young people in the United 
        States;
            ``(2) increasing awareness of adults of the impact of drug 
        abuse on young people; and
            ``(3) encouraging parents and other interested adults to 
        discuss with young people the dangers of illegal drug use.

    ``(b) Use of Funds.--
            ``(1) In general.--Amounts made available to carry out this 
        section for the national media campaign may only be used for the 
        following:
                    ``(A) The purchase of media time and space, 
                including the strategic planning for, and accounting of, 
                such purchases.
                    ``(B) Creative and talent costs, consistent with 
                paragraph (2)(A).
                    ``(C) Advertising production costs.
                    ``(D) Testing and evaluation of advertising.
                    ``(E) Evaluation of the effectiveness of the 
                national media campaign.
                    ``(F) The negotiated fees for the winning bidder on 
                requests for proposals issued either by the Office or 
                its designee to enter into contracts to carry out 
                activities authorized by this section.
                    ``(G) Partnerships with professional and civic 
                groups, community-based organizations, including faith-
                based organizations, and government organizations 
                related to the national media campaign.
                    ``(H) Entertainment industry outreach, interactive 
                outreach, media projects and activities, public 
                information, news media outreach, and corporate 
                sponsorship and participation.
                    ``(I) Operational and management expenses.
            ``(2) Specific requirements.--
                    ``(A) Creative services.--
                          ``(i) In using amounts for creative and talent 
                      costs under paragraph (1)(B), the Director shall 
                      use creative services donated at no cost to the 
                      Government (including creative services provided 
                      by the Partnership for a Drug-Free America) 
                      wherever feasible and may only procure creative 
                      services for advertising--
                                    ``(I) responding to high-priority or 
                                emergent campaign needs that cannot 
                                timely be obtained at no cost; or
                                    ``(II) intended to reach a minority, 
                                ethnic, or other special audience that 
                                cannot reasonably be obtained at no 
                                cost; or
                                    ``(III) the Director determines that 
                                the Partnership for a Drug-Free America 
                                is unable to provide, pursuant to 
                                subsection (d)(2)(B).
                          ``(ii) Subject to the availability of 
                      appropriations, no more than $1,500,000 may be 
                      expended under this section each fiscal year on 
                      creative services, except

[[Page 120 STAT. 3529]]

                      that the Director may expend up to $2,000,000 in a 
                      fiscal year on creative services to meet urgent 
                      needs of the national media campaign with advance 
                      approval from the Committee on Appropriations of 
                      the Senate and of the House of Representatives 
                      upon a showing of the circumstances causing such 
                      urgent needs of the national media campaign.
                    ``(B) Testing and evaluation of advertising.--In 
                using amounts for testing and evaluation of advertising 
                under paragraph (1)(D), the Director shall test all 
                advertisements prior to use in the national media 
                campaign to ensure that the advertisements are effective 
                and meet industry-accepted standards. The Director may 
                waive this requirement for advertisements using no more 
                than 10 percent of the purchase of advertising time 
                purchased under this section in a fiscal year and no 
                more than 10 percent of the advertising space purchased 
                under this section in a fiscal year, if the 
                advertisements respond to emergent and time-sensitive 
                campaign needs or the advertisements will not be widely 
                utilized in the national media campaign.
                    ``(C) Evaluation of effectiveness of media 
                campaign.--In using amounts for the evaluation of the 
                effectiveness of the national media campaign under 
                paragraph (1)(E), the Director shall--
                          ``(i) designate an independent entity to 
                      evaluate by April 20 of each year the 
                      effectiveness of the national media campaign based 
                      on data from--
                                    ``(I) the Monitoring the Future 
                                Study published by the Department of 
                                Health and Human Services;
                                    ``(II) the Attitude Tracking Study 
                                published by the Partnership for a Drug-
                                Free America;
                                    ``(III) the National Household 
                                Survey on Drug Abuse; and
                                    ``(IV) other relevant studies or 
                                publications, as determined by the 
                                Director, including tracking and 
                                evaluation data collected according to 
                                marketing and advertising industry 
                                standards; and
                          ``(ii) ensure that the effectiveness of the 
                      national media campaign is evaluated in a manner 
                      that enables consideration of whether the national 
                      media campaign has contributed to reduction of 
                      illicit drug use among youth and such other 
                      measures of evaluation as the Director determines 
                      are appropriate.
            ``(3) Purchase of advertising time and space.--Subject to 
        the availability of appropriations, for each fiscal year, not 
        less than 77 percent of the amounts appropriated under this 
        section shall be used for the purchase of advertising time and 
        space for the national media campaign, subject to the following 
        exceptions:
                    ``(A) In any fiscal year for which less than 
                $125,000,000 is appropriated for the national media 
                campaign, not less than 72 percent of the amounts 
                appropriated under this section shall be used for the 
                purchase of advertising time and space for the national 
                media campaign.
                    ``(B) In any fiscal year for which more than 
                $195,000,000 is appropriated under this section, not 
                less

[[Page 120 STAT. 3530]]

                than 82 percent shall be used for advertising production 
                costs and the purchase of advertising time and space for 
                the national media campaign.

    ``(c) Advertising.--In carrying out this section, the Director shall 
ensure that sufficient funds are allocated to meet the stated goals of 
the national media campaign.
    ``(d) Division of Responsibilities and Functions Under the 
Program.--
            ``(1) In general.--The Director, in consultation with the 
        Partnership for a Drug-Free America, shall determine the overall 
        purposes and strategy of the national media campaign.
            ``(2) Responsibilities.--
                    ``(A) Director.--The Director shall be responsible 
                for implementing a focused national media campaign to 
                meet the purposes set forth in subsection (a), and shall 
                approve--
                          ``(i) the strategy of the national media 
                      campaign;
                          ``(ii) all advertising and promotional 
                      material used in the national media campaign; and
                          ``(iii) the plan for the purchase of 
                      advertising time and space for the national media 
                      campaign.
                    ``(B) The partnership for a drug-free america.--The 
                Director shall request that the Partnership for a Drug-
                Free America--
                          ``(i) develop and recommend strategies to 
                      achieve the goals of the national media campaign, 
                      including addressing national and local drug 
                      threats in specific regions or States, such as 
                      methamphetamine and ecstasy;
                          ``(ii) create all advertising to be used in 
                      the national media campaign, except advertisements 
                      that are--
                                    ``(I) provided by other nonprofit 
                                entities pursuant to subsection (f);
                                    ``(II) intended to respond to high-
                                priority or emergent campaign needs that 
                                cannot timely be obtained at no cost 
                                (not including production costs and 
                                talent reuse payments), provided that 
                                any such advertising material is 
                                reviewed by the Partnership for a Drug-
                                Free America;
                                    ``(III) intended to reach a 
                                minority, ethnic, or other special 
                                audience that cannot be obtained at no 
                                cost (not including production costs and 
                                talent reuse payments), provided that 
                                any such advertising material is 
                                reviewed by the Partnership for a Drug-
                                Free America; or
                                    ``(IV) any other advertisements that 
                                the Director determines that the 
                                Partnership for a Drug-Free America is 
                                unable to provide or if the Director 
                                determines that another entity is more 
                                appropriate, subject to the requirements 
                                of subsection (b)(2)(A).
                If <<NOTE: Notification. Deadline.>> the Director 
                determines that another entity is more appropriate under 
                clause (ii)(IV), the Director shall notify Congress, 
                through the committees of jurisdiction in the House and 
                Senate, in writing, not less than 30 days prior to 
                contracting with a party other than the Partnership for 
                a Drug-Free America.

[[Page 120 STAT. 3531]]

                    ``(C) Media buying contractor.--The Director shall 
                enter into a contract with a media buying contractor to 
                plan and purchase advertising time and space for the 
                national media campaign. The media buying contractor 
                shall not provide any other service or material, or 
                conduct any other function or activity which the 
                Director determines should be provided by the 
                Partnership for a Drug-Free America.

    ``(e) Prohibitions.--None of the amounts made available under 
subsection (b) may be obligated or expended for any of the following:
            ``(1) To supplant current anti-drug community-based 
        coalitions.
            ``(2) To supplant pro bono public service time donated by 
        national and local broadcasting networks for other public 
        service campaigns.
            ``(3) For partisan political purposes, or express advocacy 
        in support of or to defeat any clearly identified candidate, 
        clearly identified ballot initiative, or clearly identified 
        legislative or regulatory proposal.
            ``(4) To fund advertising that features any elected 
        officials, persons seeking elected office, cabinet level 
        officials, or other Federal officials employed pursuant to 
        section 213 of Schedule C of title 5, Code of Federal 
        Regulations.
            ``(5) To fund advertising that does not contain a primary 
        message intended to reduce or prevent illicit drug use.
            ``(6) To fund advertising containing a primary message 
        intended to promote support for the media campaign or private 
        sector contributions to the media campaign.

    ``(f) Matching Requirement.--
            ``(1) In general.--Amounts made available under subsection 
        (b) for media time and space shall be matched by an equal amount 
        of non-Federal funds for the national media campaign, or be 
        matched with in-kind contributions of the same value.
            ``(2) No-cost match advertising direct relationship 
        requirement.--The Director shall ensure that at least 70 percent 
        of no-cost match advertising provided directly relates to 
        substance abuse prevention consistent with the specific purposes 
        of the national media campaign, except that in any fiscal year 
        in which less than $125,000,000 is appropriated to the national 
        media campaign, the Director shall ensure that at least 85 
        percent of no-cost match advertising directly relates to 
        substance abuse prevention consistent with the specific purposes 
        of the national media campaign.
            ``(3) No-cost match advertising not directly related.--The 
        Director shall ensure that no-cost match advertising that does 
        not directly relate to substance abuse prevention consistent 
        with the purposes of the national media campaign includes a 
        clear anti-drug message. Such message is not required to be the 
        primary message of the match advertising.

    ``(g) Financial and Performance Accountability.--The Director shall 
cause to be performed--
            ``(1) audits and reviews of costs of the national media 
        campaign pursuant to section 304C of the Federal Property and 
        Administrative Services Act of 1949 (41 U.S.C. 254d); and

[[Page 120 STAT. 3532]]

            ``(2) an audit to determine whether the costs of the 
        national media campaign are allowable under section 306 of such 
        Act (41 U.S.C. 256).

    ``(h) Report to Congress.--The Director shall submit on an annual 
basis a report to Congress that describes--
            ``(1) the strategy of the national media campaign and 
        whether specific objectives of the media campaign were 
        accomplished;
            ``(2) steps taken to ensure that the national media campaign 
        operates in an effective and efficient manner consistent with 
        the overall strategy and focus of the national media campaign;
            ``(3) plans to purchase advertising time and space;
            ``(4) policies and practices implemented to ensure that 
        Federal funds are used responsibly to purchase advertising time 
        and space and eliminate the potential for waste, fraud, and 
        abuse; and
            ``(5) all contracts entered into with a corporation, 
        partnership, or individual working on behalf of the national 
        media campaign.

    ``(i) Local Target Requirement.--The Director shall, to the maximum 
extent feasible, use amounts made available under this section for media 
that focuses on, or includes specific information on, prevention or 
treatment resources for consumers within specific local areas.
    ``(j) Prevention of Marijuana Use.--
            ``(1) Findings.--The Congress finds the following:
                    ``(A) 60 percent of adolescent admissions for drug 
                treatment are based on marijuana use.
                    ``(B) Potency levels of contemporary marijuana, 
                particularly hydroponically grown marijuana, are 
                significantly higher than in the past, rising from under 
                1 percent of THC in the mid-1970s to as high as 30 
                percent today.
                    ``(C) Contemporary research has demonstrated that 
                youths smoking marijuana early in life may be up to 5 
                times more likely to use hard drugs.
                    ``(D) Contemporary research has demonstrated clear 
                detrimental effects in adolescent educational 
                achievement resulting from marijuana use.
                    ``(E) Contemporary research has demonstrated clear 
                detrimental effects in adolescent brain development 
                resulting from marijuana use.
                    ``(F) An estimated 9,000,000 Americans a year drive 
                while under the influence of illegal drugs, including 
                marijuana.
                    ``(G) Marijuana smoke contains 50 to 70 percent more 
                of certain cancer causing chemicals than tobacco smoke.
                    ``(H) Teens who use marijuana are up to 4 times more 
                likely to have a teen pregnancy than teens who have not.
                    ``(I) Federal law enforcement agencies have 
                identified clear links suggesting that trade in 
                hydroponic marijuana facilitates trade by criminal 
                organizations in hard drugs, including heroin.
                    ``(J) Federal law enforcement agencies have 
                identified possible links between trade in cannabis 
                products and financing for terrorist organizations.
            ``(2) Emphasis on prevention of youth marijuana use.--In 
        conducting advertising and activities otherwise authorized

[[Page 120 STAT. 3533]]

        under this section, the Director may emphasize prevention of 
        youth marijuana use.

    ``(k) Prevention of Methamphetamine Abuse and Other Emerging Drug 
Abuse Threats.--
            ``(1) Requirement to use 10 percent of funds for 
        methamphetamine abuse prevention.--The Director shall ensure 
        that, of the amounts appropriated under this section for the 
        national media campaign for a fiscal year, not less than 10 
        percent shall be expended solely for the activities described in 
        subsection (b)(1) with respect to advertisements specifically 
        intended to reduce the use of methamphetamine.
            ``(2) Authority to use funds for other drug abuse upon 
        certification that methamphetamine abuse fell during fiscal year 
        2007.--With respect to fiscal year 2008 and any fiscal year 
        thereafter, if the Director certifies in writing to Congress 
        that domestic methamphetamine laboratory seizures (as reported 
        to the El Paso Intelligence Center of the Drug Enforcement 
        Administration) decreased to at least 75 percent of the 2006 
        level, or the Director has documented a highly, statistically 
        significant increase in a specific drug, from a baseline 
        determined by locally collected data, that can be defined as a 
        local drug crisis, the Director may apply paragraph (1)(A) for 
        that fiscal year with respect to advertisements specifically 
        intended to reduce the use of such other drugs.

    ``(l) Authorization of Appropriations.--There is authorized to be 
appropriated to the Office to carry out this section, $195,000,000 for 
each of fiscal years 2007 and 2008 and $210,000,000 for each of fiscal 
years 2009 through 2011.''.
    (b) Repeal of Superseded Provisions.--The Drug-Free Media Campaign 
Act of 1998 (21 U.S.C. 1801 et seq.) <<NOTE: 21 USC 1801-1804.>> is 
repealed.

       TITLE VI--AUTHORIZATIONS AND EXTENSION OF TERMINATION DATE

SEC. 601. AUTHORIZATION OF APPROPRIATIONS.

    Section 714 <<NOTE: 21 USC 1713.>> is amended--
            (1) by striking ``title,'' and inserting ``title except 
        activities otherwise specified,''; and
            (2) by striking ``1999 through 2003'' and inserting ``2006 
        through 2010''.
SEC. 602. EXTENSION OF TERMINATION DATE.

    Section 715(a) <<NOTE: 21 USC 1714.>> is amended by striking 
``September 30, 2003, this title and the amendments made by this title'' 
and inserting ``September 30, 2010, this title and the amendments made 
to this title''.

                      TITLE VII--ANTI-DOPING AGENCY

SEC. 701. <<NOTE: 21 USC 2001.>> DESIGNATION OF UNITED STATES 
                        ANTI-DOPING AGENCY.

    (a) Definitions.--In this title:
            (1) United states olympic committee.--The term ``United 
        States Olympic Committee'' means the organization established by 
        the ``Ted Stevens Olympic and Amateur Sports Act'' (36 U.S.C. 
        220501 et seq.).

[[Page 120 STAT. 3534]]

            (2) Amateur athletic competition.--The term ``amateur 
        athletic competition'' means a contest, game, meet, match, 
        tournament, regatta, or other event in which amateur athletes 
        compete (36 U.S.C. 220501(b)(2)).
            (3) Amateur athlete.--The term ``amateur athlete'' means an 
        athlete who meets the eligibility standards established by the 
        national governing body or paralympic sports organization for 
        the sport in which the athlete competes (36 U.S.C. 22501(b)(1)).
            (4) Gene doping.--The term ``gene doping'' means the 
        nontherapeutic use of cells, genes, genetic elements, or of the 
        modulation of gene expression, having the capacity to enhance 
        athletic performance.

    (b) In General.--The United States Anti-Doping Agency shall--
            (1) serve as the independent anti-doping organization for 
        the amateur athletic competitions recognized by the United 
        States Olympic Committee;
            (2) ensure that athletes participating in amateur athletic 
        activities recognized by the United States Olympic Committee are 
        prevented from using performance-enhancing drugs, or 
        performance-enhancing genetic modifications accomplished through 
        gene-doping;
            (3) implement anti-doping education, research, testing, and 
        adjudication programs to prevent United States Amateur Athletes 
        participating in any activity recognized by the United States 
        Olympic Committee from using performance-enhancing drugs, or 
        performance-enhancing genetic modifications accomplished through 
        gene-doping;
            (4) serve as the United States representative responsible 
        for coordination with other anti-doping organizations 
        coordinating amateur athletic competitions recognized by the 
        United States Olympic Committee to ensure the integrity of 
        athletic competition, the health of the athletes and the 
        prevention of use of performance-enhancing drugs, or 
        performance-enhancing genetic modifications accomplished through 
        gene-doping by United States amateur athletes; and
            (5) permanently include ``gene doping'' among any list of 
        prohibited substances adopted by the Agency.
SEC. 702. <<NOTE: 21 USC 2002.>> RECORDS, AUDIT, AND REPORT.

    (a) Records.--The United States Anti-Doping Agency shall keep 
correct and complete records of account.
    (b) Report.--The United States Anti-Doping Agency shall submit an 
annual report to Congress which shall include--
            (1) an audit conducted and submitted in accordance with 
        section 10101 of title 36, United States Code; and
            (2) a description of the activities of the agency.
SEC. 703. <<NOTE: 21 USC 2003.>> AUTHORIZATION OF APPROPRIATIONS.

    There are authorized to be appropriated to the United States Anti-
Doping Agency--
            (1) for fiscal year 2007, $9,700,000;
            (2) for fiscal year 2008, $10,300,000;
            (3) for fiscal year 2009, $10,600,000;
            (4) for fiscal year 2010, $11,000,000; and
            (5) for fiscal year 2011, $11,500,000.

[[Page 120 STAT. 3535]]

                    TITLE VIII--DRUG-FREE COMMUNITIES

SEC. 801. REAUTHORIZATION.

    (a) In General.--Section 1024(a) of the Drug-Free Communities Act of 
1997 (21 U.S.C. 1524(a)) is amended--
            (1) in paragraph (9), by striking ``and'' after the 
        semicolon;
            (2) in paragraph (10), by striking the period and inserting 
        a semicolon; and
            (3) by adding at the end the following:
            ``(11) $109,000,000 for fiscal year 2008;
            ``(12) $114,000,000 for fiscal year 2009;
            ``(13) $119,000,000 for fiscal year 2010;
            ``(14) $124,000,000 for fiscal year 2011; and
            ``(15) $129,000,000 for fiscal year 2012.''.

    (b) Administration Costs.--Section 1024(b) of the Drug-Free 
Communities Act of 1997 (21 U.S.C. 1524(b)) is amended to read as 
follows:
    ``(b) Administrative Costs.--
            ``(1) Limitation.--Not more than 3 percent of the funds 
        appropriated for this chapter may be used by the Office of 
        National Drug Control Policy to pay for administrative costs 
        associated with their responsibilities under the chapter.
            ``(2) Designated agency.--The agency delegated to carry out 
        this program under section 1031(d) may use up to 5 percent of 
        the funds allocated for grants under this chapter for 
        administrative costs associated with carrying out the 
        program.''.
SEC. 802. SUSPENSION OF GRANTS.

    (a) In General.--Section 1032(b) of the Drug-Free Communities Act of 
1997 (21 U.S.C. 1532(b)) is amended by adding at the end the following:
            ``(4) Process for suspension.--A grantee shall not be 
        suspended or terminated under paragraph (1)(A)(ii), (2)(A)(iii), 
        or (3)(E) unless that grantee is afforded a fair, timely, and 
        independent appeal prior to such suspension or termination.''.

    (b) Report <<NOTE: 21 USC 1532 note.>> to Congress.--Not later than 
60 days after the date of enactment of this Act, the Director of the 
Office of National Drug Control Policy shall submit to Congress a report 
detailing the appeals process required by section 1032(b)(4) of the 
Drug-Free Communities Act of 1997, as added by subsection (a).
SEC. 803. GRANT AWARD INCREASE.

    Subsections (b)(1)(A)(iv), (b)(2)(C)(i), and (b)(3)(F) of section 
1032 of the Drug-Free Communities Act of 1997 (21 U.S.C. 1532) are 
amended by striking ``$100,000'' and inserting ``$125,000''.
SEC. 804. PROHIBITION ON ADDITIONAL ELIGIBILITY CRITERIA.

    Section 1032(a) of the Drug-Free Communities Act of 1997 (21 U.S.C. 
1532(a)) is amended by adding at the end the following:
            ``(7) Additional criteria.--The Director shall not impose 
        any eligibility criteria on new applicants or renewal grantees 
        not provided in this chapter.''.
SEC. 805. NATIONAL COMMUNITY ANTI-DRUG COALITION INSTITUTE.

    Section 4 of Public Law 107-82 (21 U.S.C. 1521 note), reauthorizing 
the Drug-Free Communities Support Program, is amended--
            (1) by amending subsection (a) to read as follows:

[[Page 120 STAT. 3536]]

    ``(a) In General.--The <<NOTE: Grants.>> Director of the Office of 
National Drug Control Policy shall, using amounts authorized to be 
appropriated by subsection (d), make a directed grant to Community Anti-
Drug Coalitions of America to provide for the continuation of the 
National Community Anti-drug Coalition Institute.'';
            (2) by striking subsection (b) and redesignating subsections 
        (c) and (d) as (b) and (c), respectively; and
            (3) in subsection (c), as redesignated by paragraph (2), by 
        adding at the end the following:
            ``(4) For each of the fiscal years 2008 through 2012, 
        $2,000,000.''.

              TITLE IX--NATIONAL GUARD COUNTERDRUG SCHOOLS

SEC. 901. <<NOTE: 32 USC 112 note.>> NATIONAL GUARD COUNTERDRUG 
                        SCHOOLS.

    (a) Authority To Operate.--Under such regulations as the Secretary 
of Defense may prescribe, the Chief of the National Guard Bureau may 
establish and operate, or provide financial assistance to the States to 
establish and operate, not more than 5 schools (to be known generally as 
``National Guard counterdrug schools'').
    (b) Purpose.--The purpose of the National Guard counterdrug schools 
shall be the provision by the National Guard of training in drug 
interdiction and counterdrug activities and drug demand reduction 
activities to personnel of the following:
            (1) Federal agencies.
            (2) State, local, and tribal law enforcement agencies.
            (3) Community-based organizations engaged in such 
        activities.
            (4) Other non-Federal governmental and private entities and 
        organizations engaged in such activities.

    (c) Counterdrug Schools Specified.--The National Guard counterdrug 
schools operated under the authority in subsection (a) are as follows:
            (1) The National Interagency Civil-Military Institute 
        (NICI), San Luis Obispo, California.
            (2) The Multi-Jurisdictional Counterdrug Task Force Training 
        (MCTFT), St. Petersburg, Florida.
            (3) The Midwest Counterdrug Training Center (MCTC), 
        Johnston, Iowa.
            (4) The Regional Counterdrug Training Academy (RCTA), 
        Meridian, Mississippi.
            (5) The Northeast Regional Counterdrug Training Center 
        (NCTC), Fort Indiantown Gap, Pennsylvania.

    (d) Use of National Guard Personnel.--
            (1) In general.--To the extent provided for in the State 
        drug interdiction and counterdrug activities plan of a State in 
        which a National Guard counterdrug school is located, personnel 
        of the National Guard of that State who are ordered to perform 
        full-time National Guard duty authorized under section 112(b) of 
        that title 32, United States Code, may provide training referred 
        to in subsection (b) at that school.
            (2) Definition.--In this subsection, the term ``State drug 
        interdiction and counterdrug activities plan'', in the case of a 
        State, means the current plan submitted by the Governor

[[Page 120 STAT. 3537]]

        of the State to the Secretary of Defense under section 112 of 
        title 32, United States Code.

    (e) Treatment <<NOTE: Applicability.>> Under Authority To Provide 
Counterdrug Support.--The provisions of section 1004 of the National 
Defense Authorization Act for Fiscal Year 1991 (Public Law 101-510; 10 
U.S.C. 374 note) shall apply to any activities of a National Guard 
counterdrug school under this section that are for an agency referred to 
in subsection (a) of such section 1004 and for a purpose set forth in 
subsection (b) of such section 1004.

    (f) Annual Reports on Activities.--
            (1) In general.--Not later than February 1 each year, the 
        Secretary of Defense shall submit to Congress a report on the 
        activities of the National Guard counterdrug schools during the 
        preceding year.
            (2) Contents.--Each report under paragraph (1) shall set 
        forth the following:
                    (A) Funding.--The amount made available for each 
                National Guard counterdrug school during the fiscal year 
                ending in the year preceding the year in which such 
                report is submitted.
                    (B) Activities.--A description of the activities of 
                each National Guard counterdrug school during the year 
                preceding the year in which such report is submitted.

    (g) Authorization of Appropriations.--
            (1) In general.--There is hereby authorized to be 
        appropriated for the Department of Defense for the National 
        Guard for each of fiscal years 2006 through 2010, $30,000,000 
        for purposes of the National Guard counterdrug schools in such 
        fiscal year.
            (2) Construction.--The amount authorized to be appropriated 
        by paragraph (1) for a fiscal year is in addition to any other 
        amount authorized to be appropriated for the Department of 
        Defense for the National Guard for such fiscal year.

 TITLE <<NOTE: National Meth- amphetamine Information Clearinghouse Act 
of 2006.>> X--NATIONAL METHAMPHETAMINE INFORMATION CLEARINGHOUSE ACT OF 
2006
SEC. <<NOTE: 21 USC 2001 note.>> 1001. SHORT TITLE.

    This title may be cited as the ``National Methamphetamine 
Information Clearinghouse Act of 2006''.
SEC. <<NOTE: 21 USC 2011.>> 1002. DEFINITIONS.

    In this title--
            (1) the term ``Council'' means the National Methamphetamine 
        Advisory Council established under section 1003(b)(1);
            (2) the term ``drug endangered children'' means children 
        whose physical, mental, or emotional health are at risk because 
        of the production, use, or other effects of methamphetamine 
        production or use by another person;
            (3) the term ``National Methamphetamine Information 
        Clearinghouse'' or ``NMIC'' means the information clearinghouse 
        established under section 1003(a); and

[[Page 120 STAT. 3538]]

            (4) the term ``qualified entity'' means a State, local, or 
        tribal government, school board, or public health, law 
        enforcement, nonprofit, community anti-drug coalition, or other 
        nongovernmental organization providing services related to 
        methamphetamines.
SEC. 1003. <<NOTE: 21 USC 2012.>> ESTABLISHMENT OF CLEARINGHOUSE 
                          AND ADVISORY COUNCIL.

    (a) Clearinghouse.--There is established, under the supervision of 
the Attorney General of the United States, an information clearinghouse 
to be known as the National Methamphetamine Information Clearinghouse.
    (b) Advisory Council.--
            (1) In general.--There is established an advisory council to 
        be known as the National Methamphetamine Advisory Council.
            (2) Membership.--The Council shall consist of 10 members 
        appointed by the Attorney General--
                    (A) not fewer than 3 of whom shall be 
                representatives of law enforcement agencies;
                    (B) not fewer than 4 of whom shall be 
                representatives of nongovernmental and nonprofit 
                organizations providing services or training and 
                implementing programs or strategies related to 
                methamphetamines; and
                    (C) 1 of whom shall be a representative of the 
                Department of Health and Human Services.
            (3) Period of appointment; vacancies.--Members shall be 
        appointed for 3 years. Any vacancy in the Council shall not 
        affect its powers, but shall be filled in the same manner as the 
        original appointment.
            (4) Personnel matters.--
                    (A) Travel expenses.--The members of the Council 
                shall be allowed travel expenses, including per diem in 
                lieu of subsistence, at rates authorized for employees 
                of agencies under subchapter I of chapter 57 of title 5, 
                United States Code, while away from their homes or 
                regular places of business in the performance of 
                services for the Council.
                    (B) No compensation.--The members of the Council 
                shall not receive compensation for the performance of 
                the duties of a member of the Council.
SEC. 1004. <<NOTE: 21 USC 2013.>> NMIC REQUIREMENTS AND REVIEW.

    (a) In General.--The NMIC shall promote sharing information 
regarding successful law enforcement, treatment, environmental, 
prevention, social services, and other programs related to the 
production, use, or effects of methamphetamine and grants available for 
such programs.
    (b) Components.--The <<NOTE: Communications and tele- 
communications. Website.>> NMIC shall include--
            (1) a toll-free number; and
            (2) a website that provides a searchable database, which--
                    (A) provides information on the short-term and long-
                term effects of methamphetamine use;
                    (B) provides information regarding methamphetamine 
                treatment and prevention programs and strategies and 
                programs for drug endangered children, including 
                descriptions of successful programs and strategies and 
                contact information for such programs and strategies;

[[Page 120 STAT. 3539]]

                    (C) provides information regarding grants for 
                methamphetamine-related programs, including contact 
                information and links to websites;
                    (D) allows a qualified entity to submit items to be 
                posted on the website regarding successful public or 
                private programs or other useful information related to 
                the production, use, or effects of methamphetamine;
                    (E) includes a restricted section that may only be 
                accessed by a law enforcement organization that contains 
                successful strategies, training techniques, and other 
                information that the Council determines helpful to law 
                enforcement agency efforts to identify or combat the 
                production, use, or effects of methamphetamine;
                    (F) allows public access to all information not in a 
                restricted section; and
                    (G) contains any additional information the Council 
                determines may be useful in identifying or combating the 
                production, use, or effects of methamphetamine.

Thirty <<NOTE: Deadline. Abolishment.>> days after the website in 
paragraph (2) is operational, no funds shall be expended to continue the 
website methresources.gov.

    (c) Review of Posted Information.--
            (1) In general.--Not <<NOTE: Deadline.>> later than 30 days 
        after the date of submission of an item by a qualified entity, 
        the Council shall review an item submitted for posting on the 
        website described in subsection (b)(2)--
                    (A) to evaluate and determine whether the item, as 
                submitted or as modified, meets the requirements for 
                posting; and
                    (B) in consultation with the Attorney General, to 
                determine whether the item should be posted in a 
                restricted section of the website.
            (2) Determination.--Not <<NOTE: Deadline.>> later than 45 
        days after the date of submission of an item, the Council 
        shall--
                    (A) post the item on the website described in 
                subsection (b)(2); or
                    (B) <<NOTE: Notification.>> notify the qualified 
                entity that submitted the item regarding the reason such 
                item shall not be posted and modifications, if any, that 
                the qualified entity may make to allow the item to be 
                posted.
SEC. 1005. <<NOTE: 21 USC 2014.>> AUTHORIZATION OF APPROPRIATIONS.

    There are authorized to be appropriated--
            (1) for fiscal year 2007--
                    (A) $500,000 to establish the NMIC and Council; and
                    (B) such sums as are necessary for the operation of 
                the NMIC and Council; and
            (2) for each of fiscal years 2008 and 2009, such sums as are 
        necessary for the operation of the NMIC and Council.

                   TITLE XI--MISCELLANEOUS PROVISIONS

SEC. 1101. REPEALS.

    (a) Act.--Section 710 <<NOTE: 21 USC 1709.>> is repealed.

    (b) Forfeiture Assets.--Section 6073 of the Assets Forfeiture 
Amendments Act of 1988 (21 U.S.C. 1509) is repealed.

[[Page 120 STAT. 3540]]

SEC. 1102. CONTROLLED SUBSTANCES ACT AMENDMENTS.

    Section 303(g)(2) of the Controlled Substances Act (21 U.S.C. 
823(g)(2)) is amended--
            (1) <<NOTE: Deadline. Notification.>> in subparagraph 
        (B)(iii), by striking ``except that the'' and inserting the 
        following: ``unless, not sooner than 1 year after the date on 
        which the practitioner submitted the initial notification, the 
        practitioner submits a second notification to the Secretary of 
        the need and intent of the practitioner to treat up to 100 
        patients. A second notification under this clause shall contain 
        the certifications required by clauses (i) and (ii) of this 
        subparagraph. The''; and
            (2) in subparagraph (J)--
                    (A) in clause (i), by striking ``thereafter'' and 
                all that follows through the period and inserting 
                ``thereafter.'';
                    (B) in clause (ii), by striking ``Drug Addiction 
                Treatment Act of 2000'' and inserting ``Office of 
                National Drug Control Policy Reauthorization Act of 
                2006''; and
                    (C) in clause (iii), by striking ``this paragraph 
                should not remain in effect, this paragraph ceases to be 
                in effect'' and inserting ``subparagraph (B)(iii) should 
                be applied by limiting the total number of patients a 
                practitioner may treat to 30, then the provisions in 
                such subparagraph (B)(iii) permitting more than 30 
                patients shall not apply, effective''.
SEC. 1103. REPORT ON LAW ENFORCEMENT INTELLIGENCE SHARING.

    Not later than 180 days after the date of enactment of this Act, the 
Director shall submit to Congress a report--
            (1) evaluating existing and planned law enforcement 
        intelligence systems used by Federal, State, local, and tribal 
        law enforcement agencies responsible for drug trafficking and 
        drug production enforcement; and
            (2) addressing--
                    (A) the current law enforcement intelligence systems 
                used by Federal, State, local, and tribal law 
                enforcement agencies;
                    (B) the compatibility of such systems in ensuring 
                access and availability of law enforcement intelligence 
                to Federal, State, local, and tribal law enforcement;
                    (C) the extent to which Federal, State, local, and 
                tribal law enforcement are sharing law enforcement 
                intelligence information to assess current threats and 
                design appropriate enforcement strategies; and
                    (D) the measures needed to ensure and to promote 
                effective information sharing among law enforcement 
                intelligence systems operated by Federal, State, local, 
                and tribal law enforcement agencies responsible for drug 
                trafficking and drug production enforcement.
SEC. 1104. REQUIREMENT FOR SOUTH AMERICAN HEROIN STRATEGY.

    (a) In General.--Not <<NOTE: Deadline.>> later than 90 days after 
the date of enactment of this Act, the Director, in coordination with 
the Secretary of State, shall submit to Congress a comprehensive 
strategy that addresses the increased threat from South American heroin, 
and in particular Colombian heroin, and the emerging threat from opium 
poppy grown in Peru and often intended for transit to Columbia for 
processing into heroin.

[[Page 120 STAT. 3541]]

    (b) Contents.--The strategy submitted under subsection (a) shall 
include--
            (1) opium eradication efforts to eliminate the problem at 
        the source to prevent heroin from entering the stream of 
        commerce;
            (2) interdiction and precursor chemical controls;
            (3) demand reduction and treatment;
            (4) alternative development programs, including direct 
        assistance to regional governments to demobilize and provide 
        alternative livelihoods to former members of insurgent or other 
        groups engaged in heroin, cocoa, or other illicit drug 
        production or trafficking;
            (5) efforts to inform and involve local citizens in the 
        programs described in paragraphs (1) through (4), such as 
        through leaflets advertising rewards for information; and
            (6) an assessment of the specific level of funding and 
        resources necessary to simultaneously address the threat from 
        South American heroin and the threat from Colombian and Peruvian 
        coca.

    (c) Treatment of Classified or Law Enforcement Sensitive 
Information.--Any content of the strategy submitted under subsection (a) 
that involves information classified under criteria established by an 
Executive order, or whose public disclosure, as determined by the 
Director or the head of any relevant Federal agency, would be 
detrimental to the law enforcement of national security activities of 
any Federal, foreign, or international agency, shall be presented to 
Congress separately from the rest of the strategy.
SEC. 1105. <<NOTE: 21 USC 1701 note.>> MODEL ACTS.

    (a) In General.--The <<NOTE: Contracts.>> Director of the Office of 
National Drug Control Policy shall provide for or shall enter into an 
agreement with a non-profit corporation that is described in section 
501(c)(3) of the Internal Revenue Code of 1986 and exempt from tax under 
section 501(a) of such Code to--
            (1) advise States on establishing laws and policies to 
        address alcohol and other drug issues, based on the model State 
        drug laws developed by the President's Commission on Model State 
        Drug Laws in 1993; and
            (2) revise such model State drug laws and draft 
        supplementary model State laws to take into consideration 
        changes in the alcohol and drug abuse problems in the State 
        involved.

    (b) Authorization of Appropriations.--There is authorized to be 
appropriated to carry out this subsection $1,500,000 for each of fiscal 
years 2007 through 2011.
SEC. 1106. STUDY ON IATROGENIC ADDICTION ASSOCIATED WITH 
                          PRESCRIPTION OPIOID ANALGESIC DRUGS.

    (a) In General.--
            (1) Study.--The <<NOTE: Contracts.>> Director of the Office 
        of National Drug Control Policy shall request the Institute of 
        Medicine of the National Academy of Sciences to enter into an 
        agreement under which the Institute agrees to study certain 
        aspects of iatrogenic addiction to prescription opioid 
        analgesics included in schedules II and III of the Controlled 
        Substances Act (21 U.S.C. 812).
            (2) Iatrogenic addiction.--In this section, the term 
        ``iatrogenic addiction'' means an addiction developed from the 
        use of an opioid analgesic by an individual with no previous 
        history of any addiction, who has lawfully obtained and used the 
        drug

[[Page 120 STAT. 3542]]

        for a legitimate medical purpose by administration from, or 
        pursuant to the prescription or order of, an individual 
        practitioner acting in the usual course of professional 
        practice.

    (b) Requirements.--The study conducted pursuant to this section 
shall assess the current scientific literature to determine, if 
possible--
            (1) the rate of iatrogenic addiction associated with the 
        appropriate use of prescription drugs described in subsection 
        (a);
            (2) the impact of iatrogenic addiction associated with the 
        appropriate use of prescription drugs described in subsection 
        (a) on the individual, the prescriber, other patients, and 
        society in general;
            (3) the comparative abuse liability of prescription drugs 
        described in subsection (a) when used properly by the ultimate 
        user for a legitimate medical purpose; and
            (4)(A) what types of prospective or retrospective studies 
        should be undertaken to determine the rate of iatrogenic 
        addiction associated with the appropriate use of the 
        prescription drugs described in subsection (a); and
            (B) a feasible timeline for conducting and reporting such 
        studies, should the current state of the scientific literature 
        be insufficient to determine the rate, impact, and comparative 
        abuse liability of prescription drugs described in subsection 
        (a).

    (c) Report.--Not later than 1 year after the date of enactment of 
this Act, the Director of the Office of National Drug Control Policy 
shall ensure that the agreement under subsection (a) provides for the 
submission of a report to the Congress on the status of the study 
conducted pursuant to this section.
SEC. 1107. REQUIREMENT FOR STRATEGY TO STOP INTERNET ADVERTISING 
                          OF PRESCRIPTION MEDICINES WITHOUT A 
                          PRESCRIPTION.

    Not later <<NOTE: Deadline.>> than 120 days after the date of the 
enactment of this Act, the Director of the Office of National Drug 
Control Policy shall submit to Congress a strategy to stop 
advertisements that provide information about obtaining over the 
Internet drugs (as defined in section 702(3) of the Office of National 
Drug Control Policy Reauthorization Act of 1998) for which a 
prescription is required without the use of such a lawful prescription.
SEC. 1108. REQUIREMENT FOR STUDY ON DIVERSION AND INAPPROPRIATE 
                          USES OF PRESCRIPTION DRUGS.

    Not <<NOTE: Deadline. Reports.>> later than 90 days after the date 
of enactment of this Act, the Director of the Office of National Drug 
Control Policy, in consultation with the Secretary of Health and Human 
Services, shall submit to Congress a report that includes a plan to 
conduct a study on the illegal diversion and inappropriate uses of 
prescription drugs, including the following:
            (1) Methods to utilize both public use surveys that are in 
        existence as of the date of enactment of this Act and other 
        surveys to provide appropriate baseline data on the natural 
        history of diversion and abuse of prescription drugs that are 
        included in schedules under the Controlled Substances Act to 
        evaluate the extent and nature of potential problems with such 
        use to guide corrective actions which may reduce such problems 
        without unintentionally hindering access to these

[[Page 120 STAT. 3543]]

        drugs for legitimate medical purposes. Specifically, other 
        surveys to be considered are those that address the abuse of 
        these substances on a regional or national basis, and those that 
        address the diversion of these substances on a regional or 
        national basis.
            (2) A scientifically based analysis of the relative 
        contribution of both innate and acquired genetic factors, 
        environmental factors, psychological factors, and drug 
        characteristics that contribute to addiction to prescription 
        drugs.
SEC. 1109. REQUIREMENT FOR AFGHAN HEROIN STRATEGY.

    (a) In General.--Not <<NOTE: Deadline.>> later than 90 days after 
the date of the enactment of this Act, the Director of the Office of 
National Drug Control Policy shall submit to the Congress a 
comprehensive strategy that addresses the increased threat from Afghan 
heroin.

    (b) Contents.--The strategy shall include--
            (1) opium crop eradication efforts to eliminate the problem 
        at the source to prevent heroin from entering the stream of 
        commerce;
            (2) destruction or other direct elimination of stockpiles of 
        heroin and raw opium, and heroin production and storage 
        facilities;
            (3) interdiction and precursor chemical controls;
            (4) demand reduction and treatment;
            (5) alternative development programs;
            (6) measures to improve cooperation and coordination between 
        Federal Government agencies, and between such agencies, agencies 
        of foreign governments, and international organizations with 
        responsibility for the prevention of heroin production in, or 
        trafficking out of, Afghanistan; and
            (7) an assessment of the specific level of funding and 
        resources necessary to significantly reduce the production and 
        trafficking of heroin.

    (c) Treatment of Classified or Law Enforcement Sensitive 
Information.--Any content of the strategy that involves information 
classified under criteria established by an Executive order, or whose 
public disclosure, as determined by the Director or the head of any 
relevant Federal agency, would be detrimental to the law enforcement or 
national security activities of any Federal, foreign, or international 
agency, shall be presented to Congress separately from the rest of the 
strategy.
SEC. 1110. <<NOTE: 21 USC 1705 note.>> REQUIREMENT FOR SOUTHWEST 
                          BORDER COUNTERNARCOTICS STRATEGY.

    (a) In General.--Not <<NOTE: Deadlines.>> later than 120 days after 
the date of enactment of this Act, and every 2 years thereafter, the 
Director of National Drug Control Policy shall submit to the Congress a 
Southwest Border Counternarcotics Strategy.

    (b) Purposes.--The Southwest Border Counternarcotics Strategy 
shall--
            (1) set forth the Government's strategy for preventing the 
        illegal trafficking of drugs across the international border 
        between the United States and Mexico, including through ports of 
        entry and between ports of entry on that border;
            (2) state the specific roles and responsibilities of the 
        relevant National Drug Control Program agencies (as defined in 
        section 702 of the Office of National Drug Control Policy

[[Page 120 STAT. 3544]]

        Reauthorization Act of 1998 (21 U.S.C. 1701)) for implementing 
        that strategy; and
            (3) identify the specific resources required to enable the 
        relevant National Drug Control Program agencies to implement 
        that strategy.

    (c) Specific Content Related to Drug Tunnels Between the United 
States and Mexico.--The Southwest Border Counternarcotics Strategy shall 
include--
            (1) a strategy to end the construction and use of tunnels 
        and subterranean passages that cross the international border 
        between the United States and Mexico for the purpose of illegal 
        trafficking of drugs across such border; and
            (2) recommendations for criminal penalties for persons who 
        construct or use such a tunnel or subterranean passage for such 
        a purpose.

    (d) Consultation With Other Agencies.--The Director shall issue the 
Southwest Border Counternarcotics Strategy in consultation with the 
heads of the relevant National Drug Control Program agencies.
    (e) Limitation.--The Southwest Border Counternarcotics Strategy 
shall not change existing agency authorities or the laws governing 
interagency relationships, but may include recommendations about changes 
to such authorities or laws.
    (f) Report to Congress.--The Director shall provide a copy of the 
Southwest Border Counternarcotics Strategy to the appropriate 
congressional committees (as defined in section 702 of the Office of 
National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 
1701)), and to the Committee on Armed Services and the Committee on 
Homeland Security of the House of Representatives, and the Committee on 
Homeland Security and Governmental Affairs and the Committee on Armed 
Services of the Senate.
    (g) Treatment of Classified or Law Enforcement Sensitive 
Information.--Any content of the Southwest Border Counternarcotics 
Strategy that involves information classified under criteria established 
by an Executive order, or whose public disclosure, as determined by the 
Director or the head of any relevant National Drug Control Program 
agency, would be detrimental to the law enforcement or national security 
activities of any Federal, State, local, or tribal agency, shall be 
presented to Congress separately from the rest of the strategy.
SEC. 1111. REQUIREMENT FOR SCIENTIFIC STUDY OF MYCOHERBICIDE IN 
                          ILLICIT DRUG CROP ERADICATION.

    (a) Requirement.--Not <<NOTE: Deadline. Reports.>> later than 90 
days after the date of enactment of this Act, the Director of the Office 
of National Drug Control Policy shall submit to the Congress a report 
that includes a plan to conduct, on an expedited basis, a scientific 
study of the use of mycoherbicide as a means of illicit drug crop 
elimination by an appropriate Government scientific research entity, 
including a complete and thorough scientific peer review. The study 
shall include an evaluation of the likely human health and environmental 
impacts of mycoherbicides derived from fungus naturally existing in the 
soil.

    (b) Study.--The study required by this section shall be conducted in 
United States territory and not in any foreign country.

[[Page 120 STAT. 3545]]

SEC. 1112. REQUIREMENT FOR STUDY OF STATE PRECURSOR CHEMICAL 
                          CONTROL LAWS.

    (a) Study.--The Director of National Drug Control Policy, in 
consultation with the National Alliance for Model State Drug Laws, shall 
conduct a study of State laws with respect to precursor chemical 
controls.
    (b) Report.--Not later than 6 months after the date of the enactment 
of this Act, the Director of National Drug Control Policy shall submit a 
report to Congress on the results of the study under subsection (a), 
including--
            (1) a comparison of the State laws studied and the 
        effectiveness of each such law; and
            (2) a list of best practices observed with respect to such 
        laws.
SEC. 1113. REQUIREMENT FOR STUDY OF DRUG ENDANGERED CHILDREN 
                          PROGRAMS.

    (a) Study.--The Director of National Drug Control Policy shall 
conduct a study of methamphetamine-related activities that are conducted 
by different Drug Endangered Children programs administered by States.
    (b) Report.--Not later than 6 months after the date of the enactment 
of this Act, the Director of National Drug Control Policy shall submit 
to Congress a report on the results of the study under subsection (a). 
Such report shall include--
            (1) an analysis of the best practices of the activities 
        studied; and
            (2) recommendations for establishing a national policy to 
        address drug endangered children, based on the Drug Endangered 
        Children programs administered by States.

    (c) Definitions.--In this section--
            (1) the term ``methamphetamine-related activity'' means any 
        activity related to the production, use, or effects of 
        methamphetamine; and
            (2) the term ``drug endangered children'' means children 
        whose physical, mental, or emotional health are at risk because 
        of the production, use, or effects of methamphetamine by another 
        person.
SEC. 1114. <<NOTE: Schools.>> STUDY ON DRUG COURT HEARINGS IN 
                          NONTRADITIONAL PLACES.

    (a) Finding.--Congress finds that encouraging drug courts and 
schools to enter into partnerships that allow students to see the 
repercussions of drug abuse by non-violent offenders may serve as a 
strong deterrent and promote demand reduction.
    (b) Study.--The <<NOTE: Arkansas.>> Director of the Office of 
National Drug Control Policy shall conduct a study on drug court 
programs that conduct hearings in nontraditional public places, such as 
schools. At a minimum, the study shall evaluate similar programs in 
operation, such as the program operated in the Fourth Judicial District 
Drug Court, in Washington County, Arkansas.

    (c) Requirement.--At <<NOTE: Deadline. Reports. President.>> the 
same time the President submits to Congress the National Drug Control 
Strategy due February 1, 2007, pursuant to section 706 of the Office of 
National Drug Control Policy Reauthorization Act of 1998, the President 
shall submit to Congress a report on the study conducted under 
subsection (b). The report shall include an evaluation of the results of 
the

[[Page 120 STAT. 3546]]

study and such recommendations as the President considers appropriate.
    (d) Demand Reduction.--In this section, the term ``demand 
reduction'' has the meaning provided in section 702(1) of the Office of 
National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 
1701(1)).
SEC. 1115. REPORT ON TRIBAL GOVERNMENT PARTICIPATION IN HIDTA 
                          PROCESS.

    (a) Report Requirement.--The Director of the Office of National Drug 
Control Policy shall prepare a report for Congress on the representation 
of tribal governments in the High Intensity Drug Trafficking Areas 
Program and in high intensity drug trafficking areas designated under 
that Program. The report shall include--
            (1) a list of the tribal governments represented in the 
        Program and a description of the participation by such 
        governments in the Program;
            (2) an explanation of the rationale for the level of 
        representation by such governments; and
            (3) recommendations by the Director for methods for 
        increasing the number of tribal governments represented in the 
        Program.

    (b) Deadline.--The report prepared under subsection (a) shall be 
submitted not later than 1 year after the date of the enactment of this 
Act.
    (c) Definition.--In this section, the term ``High Intensity Drug 
Trafficking Areas Program'' means the program established under section 
707 of the Office of National Drug Control Policy Reauthorization Act of 
1998 (21 U.S.C. 1706)
SEC. 1116. REPORT ON SCHOOL DRUG TESTING.

    (a) Report Requirement.--The Director of National Drug Control 
Policy shall prepare a report on drug testing in schools. The report 
shall include a list of secondary schools that have initiated drug 
testing from among those schools that have attended conferences on drug 
testing sponsored by the Office of National Drug Control Policy.
    (b) Deadline.--Not later than 120 days after the date of the 
enactment of this Act, the Director of National Drug Control Policy 
shall submit to Congress the report required under subsection (a).
SEC. 1117. REPORT ON ONDCP PERFORMANCE BONUSES.

    (a) Report Requirement.--The Director of National Drug Control 
Policy shall prepare a report on performance bonuses at the Office of 
National Drug Control Policy. The report shall include a list of 
employees who received performance bonuses, and the amount of such 
bonuses, for the period beginning on October 1, 2004, and ending on the 
date of submission of the report.
    (b) Deadline.--Not later than 120 days after the date of the 
enactment of this Act, the Director of National Drug Control Policy 
shall submit to Congress the report required under subsection (a).
SEC. 1118. REQUIREMENT FOR DISCLOSURE OF FEDERAL SPONSORSHIP OF 
                          ALL FEDERAL ADVERTISING OR OTHER 
                          COMMUNICATION MATERIALS.

    Section <<NOTE: 21 USC 1710a.>> 712 is amended to read as follows:

[[Page 120 STAT. 3547]]

``SEC. 712. REQUIREMENT FOR DISCLOSURE OF FEDERAL SPONSORSHIP OF 
                        ALL FEDERAL ADVERTISING OR OTHER 
                        COMMUNICATION MATERIALS.

    ``(a) Requirement.--Each <<NOTE: Notice.>> advertisement or other 
communication paid for by the Office, either directly or through a 
contract awarded by the Office, shall include a prominent notice 
informing the target audience that the advertisement or other 
communication is paid for by the Office.

    ``(b) Advertisement or Other Communication.--In this section, the 
term `advertisement or other communication' includes--
            ``(1) an advertisement disseminated in any form, including 
        print or by any electronic means; and
            ``(2) a communication by an individual in any form, 
        including speech, print, or by any electronic means.''.
SEC. 1119. AWARDS FOR DEMONSTRATION PROGRAMS BY LOCAL PARTNERSHIPS 
                          TO COERCE ABSTINENCE IN CHRONIC HARD-
                          DRUG USERS UNDER COMMUNITY SUPERVISION 
                          THROUGH THE USE OF DRUG TESTING AND 
                          SANCTIONS.

    At the end of the Act, insert the following:
``SEC. 716. <<NOTE: 21 USC 1714.>> AWARDS FOR DEMONSTRATION 
                        PROGRAMS BY LOCAL PARTNERSHIPS TO COERCE 
                        ABSTINENCE IN CHRONIC HARD-DRUG USERS 
                        UNDER COMMUNITY SUPERVISION THROUGH THE 
                        USE OF DRUG TESTING AND SANCTIONS.

    ``(a) Awards Required.--The Director shall make competitive awards 
to fund demonstration programs by eligible partnerships for the purpose 
of reducing the use of illicit drugs by chronic hard-drug users living 
in the community while under the supervision of the criminal justice 
system.
    ``(b) Use of Award Amounts.--Award amounts received under this 
section shall be used--
            ``(1) to support the efforts of the agencies, organizations, 
        and researchers included in the eligible partnership;
            ``(2) to develop and field a drug testing and graduated 
        sanctions program for chronic hard-drug users living in the 
        community under criminal justice supervision; and
            ``(3) to assist individuals described in subsection (a) by 
        strengthening rehabilitation efforts through such means as job 
        training, drug treatment, or other services.

    ``(c) Eligible Partnership Defined.--In this section, the term 
`eligible partnership' means a working group whose application to the 
Director--
            ``(1) identifies the roles played, and certifies the 
        involvement of, two or more agencies or organizations, which may 
        include--
                    ``(A) State, local, or tribal agencies (such as 
                those carrying out police, probation, prosecution, 
                courts, corrections, parole, or treatment functions);
                    ``(B) Federal agencies (such as the Drug Enforcement 
                Agency, the Bureau of Alcohol, Tobacco, Firearms, and 
                Explosives, and United States Attorney offices); and
                    ``(C) community-based organizations;
            ``(2) includes a qualified researcher;
            ``(3) includes a plan for using judicial or other criminal 
        justice authority to administer drug tests to individuals 
        described in subsection (a) at least twice a week, and to 
        swiftly

[[Page 120 STAT. 3548]]

        and certainly impose a known set of graduated sanctions for non-
        compliance with community-release provisions relating to drug 
        abstinence (whether imposed as a pre-trial, probation, or parole 
        condition or otherwise);
            ``(4) includes a strategy for responding to a range of 
        substance use and abuse problems and a range of criminal 
        histories;
            ``(5) includes a plan for integrating data infrastructure 
        among the agencies and organizations included in the eligible 
        partnership to enable seamless, real-time tracking of 
        individuals described in subsection (a);
            ``(6) includes a plan to monitor and measure the progress 
        toward reducing the percentage of the population of individuals 
        described in subsection (a) who, upon being summoned for a drug 
        test, either fail to show up or who test positive for drugs.

    ``(d) Reports to Congress.--
            ``(1) Interim report.--Not later than June 1, 2009, the 
        Director shall submit to Congress a report that identifies the 
        best practices in reducing the use of illicit drugs by chronic 
        hard-drug users, including the best practices identified through 
        the activities funded under this section.
            ``(2) Final report.--Not later than June 1, 2010, the 
        Director shall submit to Congress a report on the demonstration 
        programs funded under this section, including on the matters 
        specified in paragraph (1).

    ``(e) Authorization of Appropriations.--There is authorized to be 
appropriated to carry out this section $4,900,000 for each of fiscal 
years 2007 through 2009.''.
SEC. 1120. POLICY RELATING TO SYRINGE EXCHANGE PROGRAMS.

    Section 703(a) (21 U.S.C. 1702(a)) is amended by adding at the end 
the following:
``When developing the national drug control policy, any policy of the 
Director relating to syringe exchange programs for intravenous drug 
users shall be based on the best available medical and scientific 
evidence regarding their effectiveness in promoting individual health 
and preventing the spread of infectious disease, and their impact on 
drug addiction and use. In making any policy relating to syringe 
exchange programs, the Director shall consult

[[Page 120 STAT. 3549]]

with the National Institutes of Health and the National Academy of 
Sciences.''.

    Approved December 29, 2006.

LEGISLATIVE HISTORY--H.R. 6344 (S. 2560):
---------------------------------------------------------------------------

CONGRESSIONAL RECORD, Vol. 152 (2006):
            Dec. 7, considered and passed House.
            Dec. 8, considered and passed Senate.
WEEKLY COMPILATION OF PRESIDENTIAL DOCUMENTS, Vol. 42 (2006):
            Dec. 29, Presidential statement.

                                  <all>
```